{\rtf1\adeflang1025\ansi\ansicpg1252\uc1\adeff31507\deff0\stshfdbch31505\stshfloch31506\stshfhich31506\stshfbi31507\deflang1033\deflangfe1033\themelang1033\themelangfe0\themelangcs0{\fonttbl{\f0\fbidi \froman\fcharset0\fprq2{\*\panose 02020603050405020304}Times New Roman;}{\f34\fbidi \froman\fcharset1\fprq2{\*\panose 02040503050406030204}Cambria Math;}
{\f39\fbidi \fswiss\fcharset0\fprq2{\*\panose 020b0502040204020203}Segoe UI;}{\flomajor\f31500\fbidi \froman\fcharset0\fprq2{\*\panose 02020603050405020304}Times New Roman;}
{\fdbmajor\f31501\fbidi \froman\fcharset0\fprq2{\*\panose 02020603050405020304}Times New Roman;}{\fhimajor\f31502\fbidi \froman\fcharset0\fprq2{\*\panose 02040503050406030204}Cambria;}
{\fbimajor\f31503\fbidi \froman\fcharset0\fprq2{\*\panose 02020603050405020304}Times New Roman;}{\flominor\f31504\fbidi \froman\fcharset0\fprq2{\*\panose 02020603050405020304}Times New Roman;}
{\fdbminor\f31505\fbidi \froman\fcharset0\fprq2{\*\panose 02020603050405020304}Times New Roman;}{\fhiminor\f31506\fbidi \fswiss\fcharset0\fprq2{\*\panose 020f0502020204030204}Calibri;}
{\fbiminor\f31507\fbidi \froman\fcharset0\fprq2{\*\panose 02020603050405020304}Times New Roman;}{\f40\fbidi \froman\fcharset238\fprq2 Times New Roman CE;}{\f41\fbidi \froman\fcharset204\fprq2 Times New Roman Cyr;}
{\f43\fbidi \froman\fcharset161\fprq2 Times New Roman Greek;}{\f44\fbidi \froman\fcharset162\fprq2 Times New Roman Tur;}{\f45\fbidi \froman\fcharset177\fprq2 Times New Roman (Hebrew);}{\f46\fbidi \froman\fcharset178\fprq2 Times New Roman (Arabic);}
{\f47\fbidi \froman\fcharset186\fprq2 Times New Roman Baltic;}{\f48\fbidi \froman\fcharset163\fprq2 Times New Roman (Vietnamese);}{\f430\fbidi \fswiss\fcharset238\fprq2 Segoe UI CE;}{\f431\fbidi \fswiss\fcharset204\fprq2 Segoe UI Cyr;}
{\f433\fbidi \fswiss\fcharset161\fprq2 Segoe UI Greek;}{\f434\fbidi \fswiss\fcharset162\fprq2 Segoe UI Tur;}{\f436\fbidi \fswiss\fcharset178\fprq2 Segoe UI (Arabic);}{\f437\fbidi \fswiss\fcharset186\fprq2 Segoe UI Baltic;}
{\f438\fbidi \fswiss\fcharset163\fprq2 Segoe UI (Vietnamese);}{\flomajor\f31508\fbidi \froman\fcharset238\fprq2 Times New Roman CE;}{\flomajor\f31509\fbidi \froman\fcharset204\fprq2 Times New Roman Cyr;}
{\flomajor\f31511\fbidi \froman\fcharset161\fprq2 Times New Roman Greek;}{\flomajor\f31512\fbidi \froman\fcharset162\fprq2 Times New Roman Tur;}{\flomajor\f31513\fbidi \froman\fcharset177\fprq2 Times New Roman (Hebrew);}
{\flomajor\f31514\fbidi \froman\fcharset178\fprq2 Times New Roman (Arabic);}{\flomajor\f31515\fbidi \froman\fcharset186\fprq2 Times New Roman Baltic;}{\flomajor\f31516\fbidi \froman\fcharset163\fprq2 Times New Roman (Vietnamese);}
{\fdbmajor\f31518\fbidi \froman\fcharset238\fprq2 Times New Roman CE;}{\fdbmajor\f31519\fbidi \froman\fcharset204\fprq2 Times New Roman Cyr;}{\fdbmajor\f31521\fbidi \froman\fcharset161\fprq2 Times New Roman Greek;}
{\fdbmajor\f31522\fbidi \froman\fcharset162\fprq2 Times New Roman Tur;}{\fdbmajor\f31523\fbidi \froman\fcharset177\fprq2 Times New Roman (Hebrew);}{\fdbmajor\f31524\fbidi \froman\fcharset178\fprq2 Times New Roman (Arabic);}
{\fdbmajor\f31525\fbidi \froman\fcharset186\fprq2 Times New Roman Baltic;}{\fdbmajor\f31526\fbidi \froman\fcharset163\fprq2 Times New Roman (Vietnamese);}{\fhimajor\f31528\fbidi \froman\fcharset238\fprq2 Cambria CE;}
{\fhimajor\f31529\fbidi \froman\fcharset204\fprq2 Cambria Cyr;}{\fhimajor\f31531\fbidi \froman\fcharset161\fprq2 Cambria Greek;}{\fhimajor\f31532\fbidi \froman\fcharset162\fprq2 Cambria Tur;}
{\fhimajor\f31535\fbidi \froman\fcharset186\fprq2 Cambria Baltic;}{\fhimajor\f31536\fbidi \froman\fcharset163\fprq2 Cambria (Vietnamese);}{\fbimajor\f31538\fbidi \froman\fcharset238\fprq2 Times New Roman CE;}
{\fbimajor\f31539\fbidi \froman\fcharset204\fprq2 Times New Roman Cyr;}{\fbimajor\f31541\fbidi \froman\fcharset161\fprq2 Times New Roman Greek;}{\fbimajor\f31542\fbidi \froman\fcharset162\fprq2 Times New Roman Tur;}
{\fbimajor\f31543\fbidi \froman\fcharset177\fprq2 Times New Roman (Hebrew);}{\fbimajor\f31544\fbidi \froman\fcharset178\fprq2 Times New Roman (Arabic);}{\fbimajor\f31545\fbidi \froman\fcharset186\fprq2 Times New Roman Baltic;}
{\fbimajor\f31546\fbidi \froman\fcharset163\fprq2 Times New Roman (Vietnamese);}{\flominor\f31548\fbidi \froman\fcharset238\fprq2 Times New Roman CE;}{\flominor\f31549\fbidi \froman\fcharset204\fprq2 Times New Roman Cyr;}
{\flominor\f31551\fbidi \froman\fcharset161\fprq2 Times New Roman Greek;}{\flominor\f31552\fbidi \froman\fcharset162\fprq2 Times New Roman Tur;}{\flominor\f31553\fbidi \froman\fcharset177\fprq2 Times New Roman (Hebrew);}
{\flominor\f31554\fbidi \froman\fcharset178\fprq2 Times New Roman (Arabic);}{\flominor\f31555\fbidi \froman\fcharset186\fprq2 Times New Roman Baltic;}{\flominor\f31556\fbidi \froman\fcharset163\fprq2 Times New Roman (Vietnamese);}
{\fdbminor\f31558\fbidi \froman\fcharset238\fprq2 Times New Roman CE;}{\fdbminor\f31559\fbidi \froman\fcharset204\fprq2 Times New Roman Cyr;}{\fdbminor\f31561\fbidi \froman\fcharset161\fprq2 Times New Roman Greek;}
{\fdbminor\f31562\fbidi \froman\fcharset162\fprq2 Times New Roman Tur;}{\fdbminor\f31563\fbidi \froman\fcharset177\fprq2 Times New Roman (Hebrew);}{\fdbminor\f31564\fbidi \froman\fcharset178\fprq2 Times New Roman (Arabic);}
{\fdbminor\f31565\fbidi \froman\fcharset186\fprq2 Times New Roman Baltic;}{\fdbminor\f31566\fbidi \froman\fcharset163\fprq2 Times New Roman (Vietnamese);}{\fhiminor\f31568\fbidi \fswiss\fcharset238\fprq2 Calibri CE;}
{\fhiminor\f31569\fbidi \fswiss\fcharset204\fprq2 Calibri Cyr;}{\fhiminor\f31571\fbidi \fswiss\fcharset161\fprq2 Calibri Greek;}{\fhiminor\f31572\fbidi \fswiss\fcharset162\fprq2 Calibri Tur;}
{\fhiminor\f31575\fbidi \fswiss\fcharset186\fprq2 Calibri Baltic;}{\fhiminor\f31576\fbidi \fswiss\fcharset163\fprq2 Calibri (Vietnamese);}{\fbiminor\f31578\fbidi \froman\fcharset238\fprq2 Times New Roman CE;}
{\fbiminor\f31579\fbidi \froman\fcharset204\fprq2 Times New Roman Cyr;}{\fbiminor\f31581\fbidi \froman\fcharset161\fprq2 Times New Roman Greek;}{\fbiminor\f31582\fbidi \froman\fcharset162\fprq2 Times New Roman Tur;}
{\fbiminor\f31583\fbidi \froman\fcharset177\fprq2 Times New Roman (Hebrew);}{\fbiminor\f31584\fbidi \froman\fcharset178\fprq2 Times New Roman (Arabic);}{\fbiminor\f31585\fbidi \froman\fcharset186\fprq2 Times New Roman Baltic;}
{\fbiminor\f31586\fbidi \froman\fcharset163\fprq2 Times New Roman (Vietnamese);}}{\colortbl;\red0\green0\blue0;\red0\green0\blue255;\red0\green255\blue255;\red0\green255\blue0;\red255\green0\blue255;\red255\green0\blue0;\red255\green255\blue0;
\red255\green255\blue255;\red0\green0\blue128;\red0\green128\blue128;\red0\green128\blue0;\red128\green0\blue128;\red128\green0\blue0;\red128\green128\blue0;\red128\green128\blue128;\red192\green192\blue192;}{\*\defchp 
\fs22\loch\af31506\hich\af31506\dbch\af31505 }{\*\defpap \ql \li0\ri0\sa200\sl276\slmult1\widctlpar\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0\itap0 }\noqfpromote {\stylesheet{\ql \li0\ri0\sa200\sl276\slmult1
\widctlpar\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0\itap0 \rtlch\fcs1 \af31507\afs22\alang1025 \ltrch\fcs0 \fs22\lang1033\langfe1033\loch\f31506\hich\af31506\dbch\af31505\cgrid\langnp1033\langfenp1033 \snext0 \sqformat \spriority0 Normal;}
{\*\cs10 \additive \ssemihidden \sunhideused \spriority1 Default Paragraph Font;}{\*
\ts11\tsrowd\trftsWidthB3\trpaddl108\trpaddr108\trpaddfl3\trpaddft3\trpaddfb3\trpaddfr3\trcbpat1\trcfpat1\tblind0\tblindtype3\tsvertalt\tsbrdrt\tsbrdrl\tsbrdrb\tsbrdrr\tsbrdrdgl\tsbrdrdgr\tsbrdrh\tsbrdrv \ql \li0\ri0\sa200\sl276\slmult1
\widctlpar\wrapdefault\aspalpha\aspnum\faauto\adjustright\rin0\lin0\itap0 \rtlch\fcs1 \af31507\afs22\alang1025 \ltrch\fcs0 \fs22\lang1033\langfe1033\loch\f31506\hich\af31506\dbch\af31505\cgrid\langnp1033\langfenp1033 \snext11 \ssemihidden \sunhideused 
Normal Table;}}{\*\rsidtbl \rsid12263883\rsid12990471}{\mmathPr\mmathFont34\mbrkBin0\mbrkBinSub0\msmallFrac0\mdispDef1\mlMargin0\mrMargin0\mdefJc1\mwrapIndent1440\mintLim0\mnaryLim1}{\info{\operator Wayne Liu}{\creatim\yr2016\mo5\dy3\hr16\min36}
{\revtim\yr2016\mo5\dy3\hr16\min36}{\version2}{\edmins0}{\nofpages19}{\nofwords9086}{\nofchars51796}{\nofcharsws60761}{\vern49167}}{\*\xmlnstbl {\xmlns1 http://schemas.microsoft.com/office/word/2003/wordml}}
\paperw12240\paperh15840\margl1440\margr1440\margt1440\margb1440\gutter0\ltrsect 
\widowctrl\ftnbj\aenddoc\trackmoves0\trackformatting1\donotembedsysfont0\relyonvml0\donotembedlingdata1\grfdocevents0\validatexml0\showplaceholdtext0\ignoremixedcontent0\saveinvalidxml0\showxmlerrors0\horzdoc\dghspace120\dgvspace120\dghorigin1701
\dgvorigin1984\dghshow0\dgvshow3\jcompress\viewkind1\viewscale110\rsidroot12263883 \fet0{\*\wgrffmtfilter 2450}\ilfomacatclnup0\ltrpar \sectd \ltrsect\linex0\sectdefaultcl\sftnbj {\*\pnseclvl1\pnucrm\pnstart1\pnindent720\pnhang {\pntxta .}}{\*\pnseclvl2
\pnucltr\pnstart1\pnindent720\pnhang {\pntxta .}}{\*\pnseclvl3\pndec\pnstart1\pnindent720\pnhang {\pntxta .}}{\*\pnseclvl4\pnlcltr\pnstart1\pnindent720\pnhang {\pntxta )}}{\*\pnseclvl5\pndec\pnstart1\pnindent720\pnhang {\pntxtb (}{\pntxta )}}{\*\pnseclvl6
\pnlcltr\pnstart1\pnindent720\pnhang {\pntxtb (}{\pntxta )}}{\*\pnseclvl7\pnlcrm\pnstart1\pnindent720\pnhang {\pntxtb (}{\pntxta )}}{\*\pnseclvl8\pnlcltr\pnstart1\pnindent720\pnhang {\pntxtb (}{\pntxta )}}{\*\pnseclvl9\pnlcrm\pnstart1\pnindent720\pnhang 
{\pntxtb (}{\pntxta )}}\pard\plain \ltrpar\ql \fi-720\li720\ri0\sa200\nowidctlpar\wrapdefault\faauto\rin0\lin720\itap0\pararsid12263883 \rtlch\fcs1 \af31507\afs22\alang1025 \ltrch\fcs0 
\fs22\lang1033\langfe1033\loch\af31506\hich\af31506\dbch\af31505\cgrid\langnp1033\langfenp1033 {\rtlch\fcs1 \af39\afs18 \ltrch\fcs0 \f39\fs18\insrsid12990471 \hich\af39\dbch\af31505\loch\f39 
Anonymous. 1995. Polycythemia vera: the natural history of 1213 patients followed for 20 years. Gruppo Italiano Studio Policitemia. Ann Intern Med, 123(9), 656-664. PMID: 7574220.
\par \hich\af39\dbch\af31505\loch\f39 Abdulkarim K, Girodon F, Johansson P et al. 2009. AML transformation in 56 patients with Ph- MPD in two well defined populations. Eur J Haematol, 82(2), 106-111. PMID: 19134023.
\par \hich\af39\dbch\af31505\loch\f39 Ades L, Itzykson R, and Fenaux P. 2014. Myelodysplastic syndromes. Lancet, 383\hich\af39\dbch\af31505\loch\f39 (9936), 2239-2252. PMID: 24656536.
\par \hich\af39\dbch\af31505\loch\f39 Allemani C, Weir HK, Carreira H et al. 2015. Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet, 
\hich\af39\dbch\af31505\loch\f39 385(9972), 977-1010. PMID: 25467588.
\par \hich\af39\dbch\af31505\loch\f39 Alpar D, Wren D, Ermini L et al. 2015. Clonal origins of ETV6-RUNX1(+) acute lymphoblastic leukemia: studies in monozygotic twins. Leukemia, 29(4), 839-846. PMID: 25388957.
\par \hich\af39\dbch\af31505\loch\f39 Altekruse SF, Henley SJ, and Thun MJ. 1999. De\hich\af39\dbch\af31505\loch\f39 
aths from hematopoietic and other cancers in relation to permanent hair dye use in a large prospective study (United States). Cancer Causes Control, 10(6), 617-625. PMID: 10616830.
\par \hich\af39\dbch\af31505\loch\f39 Alter BP, Giri N, Savage SA et al. 2010. Malignancies and survival patterns\hich\af39\dbch\af31505\loch\f39 
 in the National Cancer Institute inherited bone marrow failure syndromes cohort study. British Journal of Haematology, 150(2), 179-188.
\par \hich\af39\dbch\af31505\loch\f39 Alter BP, Giri N, Savage SA, and Rosenberg PS. 2009. Cancer in dyskeratosis congenita. Blood, 113(26), 6549-6557. PMCID\hich\af39\dbch\af31505\loch\f39 : PMC2710915.
\par \hich\af39\dbch\af31505\loch\f39 
American College of Radiology. 2015. Diagnostic Radiology: Computed Tomography (CT) Practice Parameters and Technical Standards.   Available from: http://www.acr.org/quality-safety/standards-guidelines/practice-guidelines-by-modality/ct  Acce
\hich\af39\dbch\af31505\loch\f39 ssed on2016.
\par \hich\af39\dbch\af31505\loch\f39 American College of Radiology. 2015. Radiation Safety.   Available from: http://www.acr.org/quality-safety/radiology-safety/radiation-safety  Accessed on2016.
\par \hich\af39\dbch\af31505\loch\f39 Anderson LA, Duncombe AS, Hughes M et al. 2012. Environmental, lifestyle, and famili\hich\af39\dbch\af31505\loch\f39 
al/ethnic factors associated with myeloproliferative neoplasms. Am J Hematol, 87(2), 175-182. PMID: 22076943.
\par \hich\af39\dbch\af31505\loch\f39 Anderson LA, Pfeiffer RM, Landgren O et al. 2009. Risks of myeloid malignancies in patients with autoimmune conditions. Br J Cancer, 100(5), 822-8\hich\af39\dbch\af31505\loch\f39 28. PMCID: PMC2653768.
\par \hich\af39\dbch\af31505\loch\f39 Arora H, Chacon AH, Choudhary S et al. 2014. Bloom syndrome. Int J Dermatol, 53(7), 798-802. PMID: 24602044.
\par \hich\af39\dbch\af31505\loch\f39 Arranz S, Chiva-Blanch G, Valderas-Martinez P et al. 2012. Wine, beer, alcohol and polyphenols on cardiovascular disease and\hich\af39\dbch\af31505\loch\f39  cancer. Nutrients, 4(7), 759-781. PMCID: PMC3407993.
\par \hich\af39\dbch\af31505\loch\f39 Babushok DV, and Bessler M. 2015. Genetic predisposition syndromes: when should they be considered in the work-up of MDS? Best Pract Res Clin Haematol, 28(1), 55-68. PMCID: PMC4323616.
\par \hich\af39\dbch\af31505\loch\f39 Bachand AM, Mundt\hich\af39\dbch\af31505\loch\f39 
 KA, Mundt DJ, and Montgomery RR. 2010. Epidemiological studies of formaldehyde exposure and risk of leukemia and nasopharyngeal cancer: a meta-analysis. Crit Rev Toxicol, 40(2), 85-100. PMID: 20085478.
\par \hich\af39\dbch\af31505\loch\f39 Ballinger ML, Mitchell G, and Thomas DM. 2015. Survei\hich\af39\dbch\af31505\loch\f39 llance recommendations for patients with germline TP53 mutations. Curr Opin Oncol, 27(4), 332-337. PMID: 26049273.
\par \hich\af39\dbch\af31505\loch\f39 Band PR, Le ND, Fang R et al. 1996. Cohort study of Air Canada pilots: mortality, cancer incidence, and leukemia risk. Am J Epidemiol, 143(2)\hich\af39\dbch\af31505\loch\f39 , 137-143. PMID: 8546114.
\par \hich\af39\dbch\af31505\loch\f39 
Barbui T. 2004. The leukemia controversy in myeloproliferative disorders: is it a natural progression of disease, a secondary sequela of therapy, or a combination of both? Semin Hematol, 41(2 Suppl 3), 15-17. PMID: 15190518.
\par \hich\af39\dbch\af31505\loch\f39 Barbu\hich\af39\dbch\af31505\loch\f39 
i T, Thiele J, Passamonti F et al. 2011. Survival and disease progression in essential thrombocythemia are significantly influenced by accurate morphologic diagnosis: an international study. J Clin Oncol, 29(23), 3179-3184. PMID: 21747083.
\par \hich\af39\dbch\af31505\loch\f39 Beane Freeman LE\hich\af39\dbch\af31505\loch\f39 
, Blair A, Lubin JH et al. 2009. Mortality from lymphohematopoietic malignancies among workers in formaldehyde industries: the National Cancer Institute Cohort. J Natl Cancer Inst, 101(10), 751-761. PMCID: PMC2684555.
\par \hich\af39\dbch\af31505\loch\f39 Beane Freeman LE, Bonner MR, Blair A e\hich\af39\dbch\af31505\loch\f39 
t al. 2005. Cancer incidence among male pesticide applicators in the Agricultural Health Study cohort exposed to diazinon. Am J Epidemiol, 162(11), 1070-1079. PMID: 16236997.
\par \hich\af39\dbch\af31505\loch\f39 Bennett JM. 2000. World Health Organization classification of the acute leukemias\hich\af39\dbch\af31505\loch\f39  and myelodysplastic syndrome. Int J Hematol, 72(2), 131-133. PMID: 11039659.
\par \hich\af39\dbch\af31505\loch\f39 Bennett JM. 2013. The myelodysplastic syndromes: a personal recollection of four decades of classification and prognostic scoring systems. Leuk Lymphoma, 54(12), 2588-2591. PMID:\hich\af39\dbch\af31505\loch\f39  23547832.

\par \hich\af39\dbch\af31505\loch\f39 
Bennett JM, Catovsky D, Daniel MT et al. 1994. The chronic myeloid leukaemias: guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukaemia. Proposals by the French-American-British Cooperati
\hich\af39\dbch\af31505\loch\f39 ve Leukaemia Group. Br J Haematol, 87(4), 746-754. PMID: 7986717.
\par \hich\af39\dbch\af31505\loch\f39 Bennett JM, Catovsky D, Daniel MT et al. 1976. Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. Br J Haematol, 33(4), 451-458. PMID
\hich\af39\dbch\af31505\loch\f39 : 188440.
\par \hich\af39\dbch\af31505\loch\f39 
Bennett JM, Catovsky D, Daniel MT et al. 1989. Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. French-American-British (FAB) Cooperative Group. J Clin Pathol, 42(6), 567-584. PMCID: PMC1141984.
\par \hich\af39\dbch\af31505\loch\f39 Bernard MP, Bancos\hich\af39\dbch\af31505\loch\f39  S, Sime PJ, and Phipps RP. 2008. Targeting cyclooxygenase-2 in hematological malignancies: rationale and promise. Curr Pharm Des, 14(21), 2051-2060. PMCID: PMC2745246.

\par \hich\af39\dbch\af31505\loch\f39 Bhatia S. 2013. Therap\hich\af39\dbch\af31505\loch\f39 y-related myelodysplasia and acute myeloid leukemia. Semin Oncol, 40(6), 666-675. PMCID: PMC3867743.
\par \hich\af39\dbch\af31505\loch\f39 Bj\loch\af39\dbch\af31505\hich\f39 \'f8\hich\af39\dbch\af31505\loch\f39 
rge T, Cnattingius S, Lie RT, Tretli S, and Engeland A. 2008. Cancer risk in children with birth defects and in their families: A population based cohor\hich\af39\dbch\af31505\loch\f39 
t study of 5.2 million children from Norway and Sweden. Cancer Epidemiology Biomarkers & Prevention, 17(3), 500-506.
\par \hich\af39\dbch\af31505\loch\f39 Bjork J, Albin M, Welinder H et al. 2001. Are occupational, hobby, or lifestyle exposures associated with Philadelphia chromosome positive \hich\af39\dbch\af31505\loch\f39 
chronic myeloid leukaemia? Occup Environ Med, 58(11), 722-727. PMCID: PMC1740065.
\par \hich\af39\dbch\af31505\loch\f39 Bjorkholm M, Derolf AR, Hultcrantz M et al. 2011. Treatment-related risk factors for transformation to acute myeloid leukemia and myelodysplastic syndromes in myeloproliferat\hich\af39\dbch\af31505\loch\f39 
ive neoplasms. J Clin Oncol, 29(17), 2410-2415. PMCID: PMC3107755.
\par \hich\af39\dbch\af31505\loch\f39 Bjorkholm M, Kristinsson SY, Landgren O, and Goldin LR. 2013. No familial aggregation in chronic myeloid leukemia. Blood, 122(3), 460-461. PMCID: PMC3716206.
\par \hich\af39\dbch\af31505\loch\f39 Blackwelder WC, Yano K, Rhoads \hich\af39\dbch\af31505\loch\f39 GG et al. 1980. Alcohol and mortality: the Honolulu Heart Study. Am J Med, 68(2), 164-169. PMID: 7355889.
\par \hich\af39\dbch\af31505\loch\f39 Blair A, and Zahm SH. 1995. Agricultural exposures and cancer. Environ Health Perspect, 103 Suppl 8, 205-208. PMCID: PMC1518967.
\par \hich\af39\dbch\af31505\loch\f39 Bochtler T, Frohling \hich\af39\dbch\af31505\loch\f39 S, and Kramer A. 2015. Role of chromosomal aberrations in clonal diversity and progression of acute myeloid leukemia. Leukemia, 29(6), 1243-1252. PMID: 25673237.
\par \hich\af39\dbch\af31505\loch\f39 Boice JD, Jr. 2006. Ionizing radiation. In: Schottenfeld D, and Fraumeni J F (Eds.), Cancer Ep\hich\af39\dbch\af31505\loch\f39 idemiology and Prevention (3rd ed., pp. 259-293). New York: Oxford University.
\par \hich\af39\dbch\af31505\loch\f39 Boice JD, Jr., Blettner M, Kleinerman RA et al. 1987. Radiation dose and leukemia risk in patients treated for cancer of the cervix. J Natl Cancer Inst, 79(6), 1295-1311. PMID: \hich\af39\dbch\af31505\loch\f39 3480381.

\par \hich\af39\dbch\af31505\loch\f39 Boice JD, Jr., Morin MM, Glass AG et al. 1991. Diagnostic x-ray procedures and risk of leukemia, lymphoma, and multiple myeloma. JAMA, 265(10), 1290-1294. PMID: 2053936.
\par \hich\af39\dbch\af31505\loch\f39 Bolufer P, Barragan E, Collado M et al. 2006. Influence of genetic polymorphi\hich\af39\dbch\af31505\loch\f39 sms on the risk of developing leukemia and on disease progression. Leuk Res, 30(12), 1471-1491.
\par \hich\af39\dbch\af31505\loch\f39 Borthakur G, Lin E, Jain N et al. 2009. Survival is poorer in patients with secondary core-binding factor acute myelogenous leukemia compared with de novo core-\hich\af39\dbch\af31505\loch\f39 
binding factor leukemia. Cancer, 115(14), 3217-3221. PMCID: PMC4184418.
\par \hich\af39\dbch\af31505\loch\f39 Brown LM, Gibson R, Burmeister LF et al. 1992. Alcohol consumption and risk of leukemia, non-Hodgkin's lymphoma, and multiple myeloma. Leuk Res, 16(10), 979-984. PMID: 1405712.
\par \hich\af39\dbch\af31505\loch\f39 Caldwel\hich\af39\dbch\af31505\loch\f39 l GG, Kelley DB, and Heath CW, Jr. 1980. Leukemia among participants in military maneuvers at a nuclear bomb test. A preliminary report. JAMA, 244(14), 1575-1578. PMID: 6932516.

\par \hich\af39\dbch\af31505\loch\f39 Campbell PJ, and Green AR. 2006. The myeloproliferative disorders. N Engl J Me\hich\af39\dbch\af31505\loch\f39 d, 355(23), 2452-2466. PMID: 17151367.
\par \hich\af39\dbch\af31505\loch\f39 Cancer Genome Atlas Research Network. 2013. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med, 368(22), 2059-2074. PMID: 23634996.
\par \hich\af39\dbch\af31505\loch\f39 Candelaria M, and Duenas-Gonzalez A. 2015. Thera\hich\af39\dbch\af31505\loch\f39 py-related myelodysplastic syndrome. Expert Opin Drug Saf, 14(5), 655-665. PMID: 25675961.
\par \hich\af39\dbch\af31505\loch\f39 Cantor KP, Blair A, Everett G et al. 1988. Hair dye use and risk of leukemia and lymphoma. Am J Public Health, 78(5), 570-571. PMCID: PMC1349342.
\par \hich\af39\dbch\af31505\loch\f39 Cardis E, Vrijheid \hich\af39\dbch\af31505\loch\f39 M, Blettner M et al. 2005. Risk of cancer after low doses of ionising radiation: retrospective cohort study in 15 countries. BMJ, 331(7508), 77. PMCID: PMC558612.
\par \hich\af39\dbch\af31505\loch\f39 Carstensen JM, Bygren LO, and Hatschek T. 1990. Cancer incidence among Swedish brewery worker\hich\af39\dbch\af31505\loch\f39 s. Int J Cancer, 45(3), 393-396. PMID: 2407667.
\par \hich\af39\dbch\af31505\loch\f39 Cartwright RA, Darwin C, McKinney PA et al. 1988. Acute myeloid leukemia in adults: a case-control study in Yorkshire. Leukemia, 2(10), 687-690. PMID: 3172845.
\par \hich\af39\dbch\af31505\loch\f39 Castillo JJ, Reagan JL, Ingham RR et al. 2012. O\hich\af39\dbch\af31505\loch\f39 
besity but not overweight increases the incidence and mortality of leukemia in adults: a meta-analysis of prospective cohort studies. Leuk Res, 36(7), 868-875. PMID: 22285508.
\par \hich\af39\dbch\af31505\loch\f39 CDC. Surgeon General's Report. 2010. Chemicals in Tobacco.
\par \hich\af39\dbch\af31505\loch\f39 Chabner B, Bertino J,\hich\af39\dbch\af31505\loch\f39 
 Cleary J et al. 2011. Cytotoxic Agents. In: Brunton L, Chabner B, and Knollmann B (Eds.), Goodman & Gilman's The Pharmacological Basis of Therapeutics (12 ed.). New York, NY: McGraw-Hill.
\par \hich\af39\dbch\af31505\loch\f39 Choi H, Jung C, Sohn SK et al. 2013. Genome-wide genotype-based ris\hich\af39\dbch\af31505\loch\f39 
k model for survival in acute myeloid leukaemia patients with normal karyotype. Br J Haematol, 163(1), 62-71. PMID: 24159609.
\par \hich\af39\dbch\af31505\loch\f39 Churpek JE, Lorenz R, Nedumgottil S et al. 2013. Proposal for the clinical detection and management of patients and their family m\hich\af39\dbch\af31505\loch\f39 
embers with familial myelodysplastic syndrome/acute leukemia predisposition syndromes. Leuk Lymphoma, 54(1), 28-35. PMID: 22691122.
\par \hich\af39\dbch\af31505\loch\f39 Cogle CR. 2015. Incidence and Burden of the Myelodysplastic Syndromes. Curr Hematol Malig Rep, 10(3), 272-281. PMID: 26134527.
\par \hich\af39\dbch\af31505\loch\f39 Cohen T, and Creger WP. 1967. Acute myeloid leukemia following seven years of aplastic anemia induced by chloramphenicol. Am J Me\hich\af39\dbch\af31505\loch\f39 d, 43(5), 762-770. PMID: 5234001.
\par \hich\af39\dbch\af31505\loch\f39 Cooper GS, Kamel F, Sandler DP, Davey FR, and Bloomfield CD. 1996. Risk of adult acute leukemia in relation to prior immune-related conditions. Cancer Epidemiol Biomarkers Prev, 5(11), 867-872. PMID: 8922293.
\par \hich\af39\dbch\af31505\loch\f39 Correa A, Moh\hich\af39\dbch\af31505\loch\f39 
an A, Jackson L, Perry H, and Helzlsouer K. 2000. Use of hair dyes, hematopoietic neoplasms, and lymphomas: a literature review. I. Leukemias and myelodysplastic syndromes. Cancer Invest, 18(4), 366-380. PMID: 10808373.
\par \hich\af39\dbch\af31505\loch\f39 Couto E, Chen B, and Hemminki K. 200\hich\af39\dbch\af31505\loch\f39 5. Association of childhood acute lymphoblastic leukaemia with cancers in family members. British Journal of Cancer, 93(11), 1307-1309.
\par \hich\af39\dbch\af31505\loch\f39 Cowell IG, Sondka Z, Smith K et al. 2012. Model for MLL translocations in therapy-related leukemia involving topoisomera\hich\af39\dbch\af31505\loch\f39 
se IIbeta-mediated DNA strand breaks and gene proximity. Proc Natl Acad Sci U S A, 109(23), 8989-8994. PMCID: PMC3384169.
\par \hich\af39\dbch\af31505\loch\f39 Craig BM, Rollison DE, List AF, and Cogle CR. 2012. Underreporting of myeloid malignancies by United States cancer registries. Cancer \hich\af39\dbch\af31505\loch\f39 
Epidemiol Biomarkers Prev, 21(3), 474-481. PMCID: 3662977.
\par \hich\af39\dbch\af31505\loch\f39 Dameshek W. 1951. Some speculations on the myeloproliferative syndromes. Blood, 6(4), 372-375. PMID: 14820991.
\par \hich\af39\dbch\af31505\loch\f39 Daniels RD, and Schubauer-Berigan MK. 2011. A meta-analysis of leukaemia risk from pro\hich\af39\dbch\af31505\loch\f39 tracted exposure to low-dose gamma radiation. Occup Environ Med, 68(6), 457-464. PMCID: PMC3095477.

\par \hich\af39\dbch\af31505\loch\f39 Darby SC, Whitley E, Howe GR et al. 1995. Radon and cancers other than lung cancer in underground miners: a collaborative analysis of 11 studies. J Natl Can\hich\af39\dbch\af31505\loch\f39 
cer Inst, 87(5), 378-384. PMID: 7853419.
\par \hich\af39\dbch\af31505\loch\f39 Debeljak M, Kitanovski L, Pajic T, and Jazbec J. 2013. Concordant acute myeloblastic leukemia in monozygotic twins with germline and shared somatic mutations in the gene for CCAAT-enhancer-binding protein alpha with
\hich\af39\dbch\af31505\loch\f39  13 years difference at onset. Haematologica, 98(7), e73-74. PMCID: PMC3696596.
\par \hich\af39\dbch\af31505\loch\f39 Delzell E, Sathiakumar N, Graff J et al. 2006. Health Effects Institute. Res Rep Health Eff Inst, 132, 1-63.
\par \hich\af39\dbch\af31505\loch\f39 Dohner H, Weisdorf DJ, and Bloomfield CD. 2015. Acute Myeloid Leuke\hich\af39\dbch\af31505\loch\f39 mia. N Engl J Med, 373(12), 1136-1152. PMID: 26376137.
\par \hich\af39\dbch\af31505\loch\f39 Doody MM, Linet MS, Glass AG et al. 1996. Risks of non-Hodgkin's lymphoma, multiple myeloma, and leukemia associated with common medications. Epidemiology, 7(2), 131-139. PMID: 8834551.
\par \hich\af39\dbch\af31505\loch\f39 Doody MM, Linet\hich\af39\dbch\af31505\loch\f39  MS, Glass AG et al. 1992. Leukemia, lymphoma, and multiple myeloma following selected medical conditions. Cancer Causes Control, 3(5), 449-456. PMID: 1525326.
\par \hich\af39\dbch\af31505\loch\f39 Dores GM, Devesa SS, Curtis RE, Linet MS, and Morton LM. 2012. Acute leukemia incidence and pati\hich\af39\dbch\af31505\loch\f39 
ent survival among children and adults in the United States, 2001-2007. Blood, 119(1), 34-43. PMID: 22086414.
\par \hich\af39\dbch\af31505\loch\f39 Drenberg CD, Paugh SW, Pounds SB et al. 2015. Inherited variation in OATP1B1 is associated with treatment outcome in acute myeloid leukemia. Clin \hich\af39\dbch\af31505\loch\f39 Pharmacol Ther. PMID: 26663398.
\par \hich\af39\dbch\af31505\loch\f39 Du Y, Fryzek J, Sekeres MA, and Taioli E. 2010. Smoking and alcohol intake as risk factors for myelodysplastic syndromes (MDS). Leuk Res, 34(1), 1-5. PMID: 19747728.
\par \hich\af39\dbch\af31505\loch\f39 Einstein AJ, Berman DS, Min JK et al. 2014. Patient-center\hich\af39\dbch\af31505\loch\f39 
ed imaging: shared decision making for cardiac imaging procedures with exposure to ionizing radiation. J Am Coll Cardiol, 63(15), 1480-1489. PMCID: PMC3994983.
\par \hich\af39\dbch\af31505\loch\f39 Elliott P, Shaddick G, Douglass M et al. 2013. Adult cancers near high-voltage overhead power li\hich\af39\dbch\af31505\loch\f39 nes. Epidemiology, 24(2), 184-190. PMID: 23337237.
\par \hich\af39\dbch\af31505\loch\f39 Evans DG, Birch JM, Ramsden RT, Sharif S, and Baser ME. 2006. Malignant transformation and new primary tumours after therapeutic radiation for benign disease: substantial risks in certain tumour prone synd
\hich\af39\dbch\af31505\loch\f39 romes. J Med Genet, 43(4), 289-294. PMCID: PMC2563223.
\par \hich\af39\dbch\af31505\loch\f39 Federman N, and Sakamoto KM. 2005. The genetic basis of bone marrow failure syndromes in children. Mol Genet Metab, 86(1-2), 100-109.
\par \hich\af39\dbch\af31505\loch\f39 Ferlay J, Soerjomataram I, Ervik M et al. 2014. Cancer Incidence an\hich\af39\dbch\af31505\loch\f39 
d Mortality Worldwide.   Available from: http://www.wcrf.org/int/cancer-facts-figures/worldwide-data  Accessed on Feb 29, 2016.
\par \hich\af39\dbch\af31505\loch\f39 Fernberg P, Odenbro A, Bellocco R et al. 2007. Tobacco use, body mass index, and the risk of leukemia and multiple myeloma: a na\hich\af39\dbch\af31505\loch\f39 
tionwide cohort study in Sweden. Cancer Res, 67(12), 5983-5986. PMID: 17575169.
\par \hich\af39\dbch\af31505\loch\f39 Ferrara F, and Schiffer CA. 2013. Acute myeloid leukaemia in adults. Lancet, 381(9865), 484-495. PMID: 23399072.
\par \hich\af39\dbch\af31505\loch\f39 Feychting M, and Ahlbom A. 1994. Magnetic fields, leukemia, and\hich\af39\dbch\af31505\loch\f39 
 central nervous system tumors in Swedish adults residing near high-voltage power lines. Epidemiology, 5(5), 501-509. PMID: 7986864.
\par \hich\af39\dbch\af31505\loch\f39 Fircanis S, Merriam P, Khan N, and Castillo JJ. 2014. The relation between cigarette smoking and risk of acute myeloid leuk\hich\af39\dbch\af31505\loch\f39 
emia: an updated meta-analysis of epidemiological studies. Am J Hematol, 89(8), E125-132. PMID: 24753145.
\par \hich\af39\dbch\af31505\loch\f39 Fleenor CJ, Higa K, Weil MM, and DeGregori J. 2015. Evolved Cellular Mechanisms to Respond to Genotoxic Insults: Implic\hich\af39\dbch\af31505\loch\f39 
ations for Radiation-Induced Hematologic Malignancies. Radiat Res, 184(4), 341-351. PMCID: PMC4617554.
\par \hich\af39\dbch\af31505\loch\f39 Fraumeni JF, Jr. 1967. Bone marrow depression induced by chloramphenicol or phenylbutazone. Leukemia and other sequelae. JAMA, 201(11), 828-834. PMID: 60\hich\af39\dbch\af31505\loch\f39 71896.
\par \hich\af39\dbch\af31505\loch\f39 Friedman GD. 1982. Phenylbutazone, musculoskeletal disease, and leukemia. J Chronic Dis, 35(4), 233-243. PMID: 7037810.
\par \hich\af39\dbch\af31505\loch\f39 Fritz A, Percy C, Jack A et al (Eds.). 2000. International Classification of Diseases for Oncology (3rd ed.). Geneva, Switzerland\hich\af39\dbch\af31505\loch\f39 : World Health Organization.
\par \hich\af39\dbch\af31505\loch\f39 Gaitonde S, Boumendjel R, Angeles R, and Rondelli D. 2010. Familial childhood monosomy 7 and associated myelodysplasia. J Pediatr Hematol Oncol, 32(6), e236-237. PMID: 20661156.
\par \hich\af39\dbch\af31505\loch\f39 Gangatharan SA, Grove CS, P'ng S et al. 2013. Acu\hich\af39\dbch\af31505\loch\f39 
te myeloid leukaemia in Western Australia 1991-2005: a retrospective population-based study of 898 patients regarding epidemiology, cytogenetics, treatment and outcome. Intern Med J, 43(8), 903-911. PMID: 23611681.
\par \hich\af39\dbch\af31505\loch\f39 Glass DC, Schnatter AR, Tang G, Irons RD,\hich\af39\dbch\af31505\loch\f39 
 and Rushton L. 2014. Risk of myeloproliferative disease and chronic myeloid leukaemia following exposure to low-level benzene in a nested case-control study of petroleum workers. Occup Environ Med, 71(4), 266-274. PMID: 24532441.
\par \hich\af39\dbch\af31505\loch\f39 Gluzman DF, Sklyarenko LM\hich\af39\dbch\af31505\loch\f39 , Koval SV et al. 2015. Myelodysplastic syndromes in Chernobyl clean-up workers. Ann Hematol, 94(10), 1639-1643. PMID: 26208666.
\par \hich\af39\dbch\af31505\loch\f39 Godley LA, and Larson RA. 2008. Therapy-related myeloid leukemia. Semin Oncol, 35(4), 418-429. PMCID: PMC2600445.
\par \hich\af39\dbch\af31505\loch\f39 Goldberg SL, \hich\af39\dbch\af31505\loch\f39 
Chen E, Corral M et al. 2010. Incidence and clinical complications of myelodysplastic syndromes among United States Medicare beneficiaries. J Clin Oncol, 28(17), 2847-2852. PMID: 20421543.
\par \hich\af39\dbch\af31505\loch\f39 Granfeldt Ostgard LS, Medeiros BC, Sengelov H et al. 2015. Epidemio\hich\af39\dbch\af31505\loch\f39 
logy and Clinical Significance of Secondary and Therapy-Related Acute Myeloid Leukemia: A National Population-Based Cohort Study. J Clin Oncol, 33(31), 3641-3649. PMID: 26304885.
\par \hich\af39\dbch\af31505\loch\f39 Greaves MF, Maia AT, Wiemels JL, and Ford AM. 2003. Leukemia in twins: lesson\hich\af39\dbch\af31505\loch\f39 s in natural history. Blood, 102(7), 2321-2333. PMID: 12791663.
\par \hich\af39\dbch\af31505\loch\f39 Greaves MF, and Wiemels J. 2003. Origins of chromosome translocations in childhood leukaemia. Nat Rev Cancer, 3(9), 639-649. PMID: 12951583.
\par \hich\af39\dbch\af31505\loch\f39 Greenberg P, Cox C, LeBeau MM et al. 1997. Internat\hich\af39\dbch\af31505\loch\f39 ional scoring system for evaluating prognosis in myelodysplastic syndromes. Blood, 89(6), 2079-2088. PMID: 9058730.
\par \hich\af39\dbch\af31505\loch\f39 Greenberg PL, Tuechler H, Schanz J et al. 2012. Revised international prognostic scoring system for myelodysplastic syndromes. Blood, 120(12\hich\af39\dbch\af31505\loch\f39 ), 2454-2465. PMID: 22740453.
\par \hich\af39\dbch\af31505\loch\f39 Griem ML, Kleinerman RA, Boice JD, Jr. et al. 1994. Cancer following radiotherapy for peptic ulcer. J Natl Cancer Inst, 86(11), 842-849. PMID: 8182765.
\par \hich\af39\dbch\af31505\loch\f39 Grimwade D. 2001. The clinical significance of cytogenetic abnormalities i\hich\af39\dbch\af31505\loch\f39 n acute myeloid leukaemia. Best Pract Res Clin Haematol, 14(3), 497-529. PMID: 11640867.
\par \hich\af39\dbch\af31505\loch\f39 Grimwade D, Hills RK, Moorman AV et al. 2010. Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recu\hich\af39\dbch\af31505\loch\f39 
rring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials. Blood, 116(3), 354-365. PMID: 20385793.
\par \hich\af39\dbch\af31505\loch\f39 Groves FD, Page WF, Gridley G et al. 2002. Cancer in Korean war navy technicians: morta\hich\af39\dbch\af31505\loch\f39 lity survey after 40 years. Am J Epidemiol, 155(9), 810-818. PMID: 11978584.
\par \hich\af39\dbch\af31505\loch\f39 Gundestrup M, and Storm HH. 1999. Radiation-induced acute myeloid leukaemia and other cancers in commercial jet cockpit crew: a population-based cohort study. Lancet, 354(9195), 2\hich\af39\dbch\af31505\loch\f39 
029-2031. PMID: 10636367.
\par \hich\af39\dbch\af31505\loch\f39 Hahn CN, Chong CE, Carmichael CL et al. 2011. Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia. Nat Genet, 43(10), 1012-1017. PMCID: PMC3184204.
\par \hich\af39\dbch\af31505\loch\f39 Hammer GP, Auvinen A, De Stavol\hich\af39\dbch\af31505\loch\f39 
a BL et al. 2014. Mortality from cancer and other causes in commercial airline crews: a joint analysis of cohorts from 10 countries. Occup Environ Med, 71(5), 313-322. PMID: 24389960.
\par \hich\af39\dbch\af31505\loch\f39 Harada H, Harada Y, Tanaka H, Kimura A, and Inaba T. 2003. Implications \hich\af39\dbch\af31505\loch\f39 
of somatic mutations in the AML1 gene in radiation-associated and therapy-related myelodysplastic syndrome/acute myeloid leukemia. Blood, 101(2), 673-680. PMID: 12393679.
\par \hich\af39\dbch\af31505\loch\f39 Hauptmann M, Lubin JH, Stewart PA, Hayes RB, and Blair A. 2003. Mortality from lympho\hich\af39\dbch\af31505\loch\f39 
hematopoietic malignancies among workers in formaldehyde industries. J Natl Cancer Inst, 95(21), 1615-1623. PMID: 14600094.
\par \hich\af39\dbch\af31505\loch\f39 Hauptmann M, Stewart PA, Lubin JH et al. 2009. Mortality from lymphohematopoietic malignancies and brain cancer among embalmers expo\hich\af39\dbch\af31505\loch\f39 
sed to formaldehyde. J Natl Cancer Inst, 101(24), 1696-1708. PMCID: PMC2794303.
\par \hich\af39\dbch\af31505\loch\f39 Hayes RB, Yin SN, Dosemeci M et al. 1997. Benzene and the dose-related incidence of hematologic neoplasms in China. Chinese Academy of Preventive Medicine--National Cancer Inst\hich\af39\dbch\af31505\loch\f39 
itute Benzene Study Group. J Natl Cancer Inst, 89(14), 1065-1071. PMID: 9230889.
\par \hich\af39\dbch\af31505\loch\f39 Hemminki K, Liu X, Forsti A et al. 2013. Subsequent leukaemia in autoimmune disease patients. Br J Haematol, 161(5), 677-687. PMID: 23565673.
\par \hich\af39\dbch\af31505\loch\f39 Henshaw DL, Eatough JP, and Richardson RB. 1990. Radon as a causative factor in induction of myeloid leukaemia and other cancers. Lancet, 335(8696), 1008-1012. PMID: 1970069.
\par \hich\af39\dbch\af31505\loch\f39 Hinds MW, Kolonel LN, Lee J, and Hirohata T. 1980. Associations between cancer in\hich\af39\dbch\af31505\loch\f39 
cidence and alcohol/cigarette consumption among five ethnic groups in Hawaii. Br J Cancer, 41(6), 929-940. PMCID: PMC2010370.
\par \hich\af39\dbch\af31505\loch\f39 Hoffman R, Benz EJ, Jr., Silberstein LE et al. 2013. Hematology: Basic Principles and Practice.  6th ed. Philadelphia: Saunders/El\hich\af39\dbch\af31505\loch\f39 sevier.
\par \hich\af39\dbch\af31505\loch\f39 Howard R, Gilbert E, Lynch CF et al. 2008. Risk of leukemia among survivors of testicular cancer: a population-based study of 42,722 patients. Ann Epidemiol, 18(5), 416-421. PMCID: PMC4034178.
\par \hich\af39\dbch\af31505\loch\f39 Hsu WL, Preston DL, Soda M et al. 2013. The incidence o\hich\af39\dbch\af31505\loch\f39 f leukemia, lymphoma and multiple myeloma among atomic bomb survivors: 1950-2001. Radiat Res, 179(3), 361-382. PMCID: PMC3875218.

\par \hich\af39\dbch\af31505\loch\f39 IARC. 2001. Ionizing radiation, part 2: some internally deposited radionuclides. IARC Monogr Eval Carcinog Risks Hum, 78, 595.
\par \hich\af39\dbch\af31505\loch\f39 IARC. 2008. 1,3-butadiene, ethylene oxide and vinyl halides (vinyl fluoride, vinyl chloride and vinyl bromide). IARC Monogr Eval Carcinog Risks Hum, 97, 510.
\par \hich\af39\dbch\af31505\loch\f39 IARC. 2010. Some aromatic amines, organic dyes and related exposures. IARC Monogr Eval Carcinog R\hich\af39\dbch\af31505\loch\f39 isks Hum, 99. Personal use of hair dyes pgs 558-658. Lyon, France: IARC.
\par \hich\af39\dbch\af31505\loch\f39 IARC. 2012. Chemical and related occupations. IARC Monogr Eval Carcinog Risks Hum 100 (Pt F). Benzene pgs 249-294. Butadiene pgs 309-338. Dioxins and related pgs 339-378. Formaldehyde\hich\af39\dbch\af31505\loch\f39 
 pgs 401-435. Occupational exposure in the rubber manufacturing industry pgs 541-562. Lyon, France: IARC.
\par \hich\af39\dbch\af31505\loch\f39 IARC. 2013. Non-ionizing radiation, part 2: radiofrequency electromagnetic fields. IARC Monogr Eval Carcinog Risks Hum, 102, 460.
\par \hich\af39\dbch\af31505\loch\f39 Ido M, Nagata C, Kaw\hich\af39\dbch\af31505\loch\f39 akami N et al. 1996. A case-control study of myelodysplastic syndromes among Japanese men and women. Leuk Res, 20(9), 727-731. PMID: 8947581.
\par \hich\af39\dbch\af31505\loch\f39 Inaba H, Greaves M, and Mullighan CG. 2013. Acute lymphoblastic leukaemia. Lancet, 381(9881), 1943-1955. PMCID: PM\hich\af39\dbch\af31505\loch\f39 C3816716.
\par \hich\af39\dbch\af31505\loch\f39 IOM (Institute of Medicine). 2000. The Five Series Study: Mortality of Military Participants in U.S. Nuclear Weapons Tests. Washington, DC: National Academy Press.
\par \hich\af39\dbch\af31505\loch\f39 Iwanaga M, Hsu WL, Soda M et al. 2011. Risk of myelodysplastic syndromes in people\hich\af39\dbch\af31505\loch\f39 
 exposed to ionizing radiation: a retrospective cohort study of Nagasaki atomic bomb survivors. J Clin Oncol, 29(4), 428-434. PMID: 21149671.
\par \hich\af39\dbch\af31505\loch\f39 Jablon S, Hrubec Z, and Boice JD, Jr. 1991. Cancer in populations living near nuclear facilities. A survey of mort\hich\af39\dbch\af31505\loch\f39 
ality nationwide and incidence in two states. JAMA, 265(11), 1403-1408. PMID: 1999880.
\par \hich\af39\dbch\af31505\loch\f39 Jaffe ES, Harris NL, Stein H, and Vardiman JW (Eds.). 2001. World Health Organization classification of tumours. Pathology and genetics of haematopoietic and lymphoid ti\hich\af39\dbch\af31505\loch\f39 
ssues. Lyon: IARC Press.
\par \hich\af39\dbch\af31505\loch\f39 James C, Ugo V, Le Couedic JP et al. 2005. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature, 434(7037), 1144-1148. PMID: 15793561.
\par \hich\af39\dbch\af31505\loch\f39 Johansen C, Raaschou Nielsen O, Olsen JH, and Schu\hich\af39\dbch\af31505\loch\f39 
z J. 2007. Risk for leukaemia and brain and breast cancer among Danish utility workers: a second follow-up. Occup Environ Med, 64(11), 782-784. PMCID: PMC2078420.
\par \hich\af39\dbch\af31505\loch\f39 Kabat GC, Wu JW, Moore SC et al. 2013. Lifestyle and dietary factors in relation to risk of c\hich\af39\dbch\af31505\loch\f39 
hronic myeloid leukemia in the NIH-AARP Diet and Health Study. Cancer Epidemiol Biomarkers Prev, 22(5), 848-854. PMCID: PMC3849026.
\par \hich\af39\dbch\af31505\loch\f39 Kadia TM, Ravandi F, Cortes J, and Kantarjian H. 2015. Toward Individualized Therapy in Acute Myeloid Leukemia: A Contempora\hich\af39\dbch\af31505\loch\f39 ry Review. JAMA Oncol, 1(6), 820-828. PMID: 26181162.
\par \hich\af39\dbch\af31505\loch\f39 Karmali R, Dalovisio A, Borgia JA et al. 2015. All in the family: Clueing into the link between metabolic syndrome and hematologic malignancies. Blood Rev, 29(2), 71-80. PMID: 25433571.
\par \hich\af39\dbch\af31505\loch\f39 Karran P. 2006. \hich\af39\dbch\af31505\loch\f39 Thiopurines, DNA damage, DNA repair and therapy-related cancer. Br Med Bull, 79-80, 153-170. PMID: 17277075.
\par \hich\af39\dbch\af31505\loch\f39 Kasum CM, Blair CK, Folsom AR, and Ross JA. 2003. Non-steroidal anti-inflammatory drug use and risk of adult leukemia. Cancer Epidemiol Biomarkers \hich\af39\dbch\af31505\loch\f39 Prev, 12(6), 534-537. PMID: 12814999.

\par \hich\af39\dbch\af31505\loch\f39 Kaye FJ. 2009. Mutation-associated fusion cancer genes in solid tumors. Mol Cancer Ther, 8(6), 1399-1408. PMID: 19509239.
\par \hich\af39\dbch\af31505\loch\f39 Khalade A, Jaakkola MS, Pukkala E, and Jaakkola JJ. 2010. Exposure to benzene at work and the ri\hich\af39\dbch\af31505\loch\f39 
sk of leukemia: a systematic review and meta-analysis. Environ Health, 9, 31. PMCID: PMC2903550.
\par \hich\af39\dbch\af31505\loch\f39 Kheifets L, Monroe J, Vergara X, Mezei G, and Afifi AA. 2008. Occupational electromagnetic fields and leukemia and brain cancer: an update to two meta-analyses\hich\af39\dbch\af31505\loch\f39 
. J Occup Environ Med, 50(6), 677-688. PMID: 18545095.
\par \hich\af39\dbch\af31505\loch\f39 Kheifets LI, Afifi AA, Buffler PA, Zhang ZW, and Matkin CC. 1997. Occupational electric and magnetic field exposure and leukemia. A meta-analysis. J Occup Environ Med, 39(11), 1074-1091. PMID: 9383718.
\par \hich\af39\dbch\af31505\loch\f39 Khincha PP, and Savage SA. 2013. Genomic characterization of the inherited bone marrow failure syndromes. Semin Hematol, 50(4), 333-347. PMCID: PMC3835370.
\par \hich\af39\dbch\af31505\loch\f39 Kilpivaara O, Mukherjee S, Schram AM et al. 2009. A germline JAK2 SNP is associated with predisposition to the development of JAK2(V617F)-positive myeloproliferative neoplasms. Nat Genet, 41(4), 455-459. PMCID: PMC3676425.

\par \hich\af39\dbch\af31505\loch\f39 Kim DH, Lee ST, Won HH et al. 201\hich\af39\dbch\af31505\loch\f39 
1. A genome-wide association study identifies novel loci associated with susceptibility to chronic myeloid leukemia. Blood, 117(25), 6906-6911. PMID: 21540461.
\par \hich\af39\dbch\af31505\loch\f39 Kinlen LJ, and Rogot E. 1988. Leukaemia and smoking habits among United States veterans. BMJ, 29\hich\af39\dbch\af31505\loch\f39 7(6649), 657-659. PMCID: PMC1834341.
\par \hich\af39\dbch\af31505\loch\f39 Kipps TJ, and Huan-You W. 2015. Classification of malignant lymphoid disorders Williams Hematatology (8th ed.).
\par \hich\af39\dbch\af31505\loch\f39 Knight JA, Skol AD, Shinde A et al. 2009. Genome-wide association study to identify novel loci associated w\hich\af39\dbch\af31505\loch\f39 
ith therapy-related myeloid leukemia susceptibility. Blood, 113(22), 5575-5582. PMCID: PMC2689055.
\par \hich\af39\dbch\af31505\loch\f39 Koeman T, van den Brandt PA, Slottje P et al. 2014. Occupational extremely low-frequency magnetic field exposure and selected cancer outcomes in a prospectiv\hich\af39\dbch\af31505\loch\f39 
e Dutch cohort. Cancer Causes Control, 25(2), 203-214. PMID: 24241907.
\par \hich\af39\dbch\af31505\loch\f39 Kralovics R, Passamonti F, Buser AS et al. 2005. A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med, 352(17), 1779-1790. PMID: 15858187.
\par \hich\af39\dbch\af31505\loch\f39 Krestinina L, Pre\hich\af39\dbch\af31505\loch\f39 
ston DL, Davis FG et al. 2010. Leukemia incidence among people exposed to chronic radiation from the contaminated Techa River, 1953-2005. Radiat Environ Biophys, 49(2), 195-201. PMID: 20012750.
\par \hich\af39\dbch\af31505\loch\f39 Kristinsson SY, Bjorkholm M, Hultcrantz M et al. 2011. Chronic\hich\af39\dbch\af31505\loch\f39 
 immune stimulation might act as a trigger for the development of acute myeloid leukemia or myelodysplastic syndromes. J Clin Oncol, 29(21), 2897-2903. PMCID: PMC3138717.
\par \hich\af39\dbch\af31505\loch\f39 Kroll ME, Murphy F, Pirie K et al. 2012. Alcohol drinking, tobacco smoking and subtyp\hich\af39\dbch\af31505\loch\f39 
es of haematological malignancy in the UK Million Women Study. Br J Cancer, 107(5), 879-887. PMCID: PMC3425977.
\par \hich\af39\dbch\af31505\loch\f39 Lan Q, Zhang L, Li G et al. 2004. Hematotoxicity in workers exposed to low levels of benzene. Science, 306(5702), 1774-1776. PMCID: PMC1256034.
\par \hich\af39\dbch\af31505\loch\f39 
Landgren O, Goldin LR, Kristinsson SY et al. 2008. Increased risks of polycythemia vera, essential thrombocythemia, and myelofibrosis among 24,577 first-degree relatives of 11,039 patients with myeloproliferative neoplasms in Sweden. Blood, 112(6), 2199-2
\hich\af39\dbch\af31505\loch\f39 2\hich\af39\dbch\af31505\loch\f39 04. PMCID: PMC2532797.
\par \hich\af39\dbch\af31505\loch\f39 Larsson SC, and Wolk A. 2008. Overweight and obesity and incidence of leukemia: a meta-analysis of cohort studies. Int J Cancer, 122(6), 1418-1421. PMID: 18027857.
\par \hich\af39\dbch\af31505\loch\f39 Laurier D, Jacob S, Bernier MO et al. 2008. Epidemiological studies o\hich\af39\dbch\af31505\loch\f39 
f leukaemia in children and young adults around nuclear facilities: a critical review. Radiat Prot Dosimetry, 132(2), 182-190. PMID: 18922823.
\par \hich\af39\dbch\af31505\loch\f39 Laurier D, Valenty M, and Tirmarche M. 2001. Radon exposure and the risk of leukemia: a review of epidemiological\hich\af39\dbch\af31505\loch\f39  studies. Health Phys, 81(3), 272-288. PMID: 11513461.
\par \hich\af39\dbch\af31505\loch\f39 Leal AD, Thompson CA, Wang AH et al. 2014. Anthropometric, medical history and lifestyle risk factors for myeloproliferative neoplasms in the Iowa Women's Health Study cohort. Int J Cancer, 134(7), 174
\hich\af39\dbch\af31505\loch\f39 1-1750. PMCID: PMC3947165.
\par \hich\af39\dbch\af31505\loch\f39 Lee WJ, Hoppin JA, Blair A et al. 2004. Cancer incidence among pesticide applicators exposed to alachlor in the Agricultural Health Study. Am J Epidemiol, 159(4), 373-380. PMID: 14769641.
\par \hich\af39\dbch\af31505\loch\f39 Lehmann S, Ravn A, Carlsson L et al. 2011\hich\af39\dbch\af31505\loch\f39 
. Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish Adult Acute Leukemia Registry. Leukemia, 25(7), 1128-1134. PMID: 21502956.
\par \hich\af39\dbch\af31505\loch\f39 Leone G, Fianchi L, Pagano L, and Voso MT. 2010. Incidence and suscept\hich\af39\dbch\af31505\loch\f39 ibility to therapy-related myeloid neoplasms. Chem Biol Interact, 184(1-2), 39-45. PMID: 20026017.
\par \hich\af39\dbch\af31505\loch\f39 Leuraud K, Richardson DB, Cardis E et al. 2015. Ionising radiation and risk of death from leukaemia and lymphoma in radiation-monitored workers (INWORKS): an\hich\af39\dbch\af31505\loch\f39 
 international cohort study. Lancet Haematol, 2(7), e276-e281. PMCID: PMC4587986.
\par \hich\af39\dbch\af31505\loch\f39 Li Y, Moysich KB, Baer MR et al. 2006. Intakes of selected food groups and beverages and adult acute myeloid leukemia. Leuk Res, 30(12), 1507-1515. PMID: 16678899.
\par \hich\af39\dbch\af31505\loch\f39 Lichtman M\hich\af39\dbch\af31505\loch\f39 A. 2015. Classification and clinical manifestations of the clonal myeloid disorders Willliams Hematology (8th ed.).
\par \hich\af39\dbch\af31505\loch\f39 Linet MS. 1985. The Leukemias: Epidemiological Aspects. New York: Oxford University Press.
\par \hich\af39\dbch\af31505\loch\f39 Linet MS, and Cartwright RA. 1988. Chronic lympho\hich\af39\dbch\af31505\loch\f39 cytic leukemia: epidemiology and etiologic findings. Nouv Rev Fr Hematol, 30(5-6), 353-357. PMID: 3222144.
\par \hich\af39\dbch\af31505\loch\f39 Linet MS, Devesa SS, and Morgan GJ. 2006. The Leukemias. In: Schottenfeld D, and Fraumeni J F (Eds.), Cancer Epidemiology and Prevention (3rd ed., pp\hich\af39\dbch\af31505\loch\f39 
. 841-871). New York: Oxford University Press.
\par \hich\af39\dbch\af31505\loch\f39 Linet MS, Kim KP, Miller DL et al. 2010. Historical review of occupational exposures and cancer risks in medical radiation workers. Radiat Res, 174(6), 793-808. PMCID: PMC4098897.
\par \hich\af39\dbch\af31505\loch\f39 Linet MS, Slovis TL, Miller DL et al. 2012. Cancer risks associated with external radiation from diagnostic imaging procedures. CA Cancer J Clin, 62(2), 75-100. PMCID: PMC3548988.
\par \hich\af39\dbch\af31505\loch\f39 Linet MS, Yin SN, Gilbert ES et al. 2015. A retrospective cohort study of ca\hich\af39\dbch\af31505\loch\f39 
use-specific mortality and incidence of hematopoietic malignancies in Chinese benzene-exposed workers. Int J Cancer, 137(9), 2184-2197. PMID: 25944549.
\par \hich\af39\dbch\af31505\loch\f39 Liu P, Holman CD, Jin J, and Zhang M. 2015. Dietary isoflavone intake is associated with a reduced risk \hich\af39\dbch\af31505\loch\f39 of myelodysplastic syndromes. Br J Nutr, 114(12), 2110-2115. PMID: 26458988.
\par \hich\af39\dbch\af31505\loch\f39 Liu P, Holman CD, Jin J, and Zhang M. 2016. Alcohol consumption and risk of myelodysplastic syndromes: a case-control study. Cancer Causes Control, 27(2), 209-216. PMID: 26590915.
\par \hich\af39\dbch\af31505\loch\f39 Ludwig A, Jochmann N, Kertesz A et al. 2010. Smoking decreases the level of circulating CD34+ progenitor cells in young healthy women--a pilot study. BMC Womens Health, 10, 20. PMCID: PMC2891626.
\par \hich\af39\dbch\af31505\loch\f39 Ma X, Lim U, Park Y et al. 2009. Obesity, lifestyle factors\hich\af39\dbch\af31505\loch\f39 , and risk of myelodysplastic syndromes in a large US cohort. Am J Epidemiol, 169(12), 1492-1499. PMCID: PMC2727203.
\par \hich\af39\dbch\af31505\loch\f39 Ma X, Park Y, Mayne ST et al. 2010. Diet, lifestyle, and acute myeloid leukemia in the NIH-AARP cohort. Am J Epidemiol, 171(3), 312-322. PM\hich\af39\dbch\af31505\loch\f39 CID: PMC2842202.
\par \hich\af39\dbch\af31505\loch\f39 
Mabuchi K, Fugiwara S, Preston DL, Nakamura N, and Shore RE. 2011. Atomic bomb survivors: long-term health effects of radiation. In: Shrieve D S, and Loeffler J S (Eds.), Human Radiation Injury. Philadelphia: Wolters Kuwer/Lippincott Willi
\hich\af39\dbch\af31505\loch\f39 ams and Wilkins.
\par \hich\af39\dbch\af31505\loch\f39 Mahajan R, Blair A, Lynch CF et al. 2006. Fonofos exposure and cancer incidence in the agricultural health study. Environ Health Perspect, 114(12), 1838-1842. PMCID: PMC1764168.
\par \hich\af39\dbch\af31505\loch\f39 Mangan JK, and Speck NA. 2011. RUNX1 mutations in clonal myel\hich\af39\dbch\af31505\loch\f39 
oid disorders: from conventional cytogenetics to next generation sequencing, a story 40 years in the making. Crit Rev Oncog, 16(1-2), 77-91. PMCID: PMC3248792.
\par \hich\af39\dbch\af31505\loch\f39 March HC. 1950. Leukemia in radiologists in a 20 year period. Am J Med Sci, 220(3), 282-286. PMI\hich\af39\dbch\af31505\loch\f39 D: 14771053.
\par \hich\af39\dbch\af31505\loch\f39 
Matsuo T, Tomonaga M, Bennett JM et al. 1988. Reclassification of leukemia among A-bomb survivors in Nagasaki using French-American-British (FAB) classification for acute leukemia. Jpn J Clin Oncol, 18(2), 91-96. PMID: 2898029.
\par \hich\af39\dbch\af31505\loch\f39 Maynadie M, Gir\hich\af39\dbch\af31505\loch\f39 
odon F, Manivet-Janoray I et al. 2011. Twenty-five years of epidemiological recording on myeloid malignancies: data from the specialized registry of hematologic malignancies of Cote d'Or (Burgundy, France). Haematologica, 96(1), 55-61. PMID: 20971817.

\par \hich\af39\dbch\af31505\loch\f39 Mc L\hich\af39\dbch\af31505\loch\f39 aughlin J. 2012. An historical overview of radon and its progeny: applications and health effects. Radiat Prot Dosimetry, 152(1-3), 2-8. PMID: 22914338.
\par \hich\af39\dbch\af31505\loch\f39 McHale CM, Zhang L, and Smith MT. 2012. Current understanding of the mechanism of benzene-induced leuke\hich\af39\dbch\af31505\loch\f39 
mia in humans: implications for risk assessment. Carcinogenesis, 33(2), 240-252. PMCID: PMC3271273.
\par \hich\af39\dbch\af31505\loch\f39 McKenna RW. 2000. Multifaceted approach to the diagnosis and classification of acute leukemias. Clin Chem, 46(8 Pt 2), 1252-1259. PMID: 10926919.
\par \hich\af39\dbch\af31505\loch\f39 McKeown SR\hich\af39\dbch\af31505\loch\f39 
, Hatfield P, Prestwich RJ, Shaffer RE, and Taylor RE. 2015. Radiotherapy for benign disease; assessing the risk of radiation-induced cancer following exposure to intermediate dose radiation. Br J Radiol, 88(1056), 20150405. PMID: 26462717.
\par \hich\af39\dbch\af31505\loch\f39 McNally RJ, Rom\hich\af39\dbch\af31505\loch\f39 an E, and Cartwright RA. 1999. Leukemias and lymphomas: time trends in the UK, 1984-93. Cancer Causes Control, 10(1), 35-42. PMID: 10334640.
\par \hich\af39\dbch\af31505\loch\f39 McQuilten ZK, Wood EM, Polizzotto MN et al. 2014. Underestimation of myelodysplastic syndrome incidence by cancer r\hich\af39\dbch\af31505\loch\f39 
egistries: Results from a population-based data linkage study. Cancer, 120(11), 1686-1694. PMID: 24643720.
\par \hich\af39\dbch\af31505\loch\f39 Mele A, Visani G, Pulsoni A et al. 1996. Risk factors for essential thrombocythemia: A case-control study. Italian Leukemia Study Group. Cancer, 77(1\hich\af39\dbch\af31505\loch\f39 0), 2157-2161. PMID: 8640685.
\par \hich\af39\dbch\af31505\loch\f39 Melo JV, and Barnes DJ. 2007. Chronic myeloid leukaemia as a model of disease evolution in human cancer. Nat Rev Cancer, 7(6), 441-453. PMID: 17522713.
\par \hich\af39\dbch\af31505\loch\f39 Mesa RA, Li CY, Ketterling RP et al. 2005. Leukemic transformation in myel\hich\af39\dbch\af31505\loch\f39 
ofibrosis with myeloid metaplasia: a single-institution experience with 91 cases. Blood, 105(3), 973-977. PMID: 15388582.
\par \hich\af39\dbch\af31505\loch\f39 Mesa RA, Loegering D, Powell HL et al. 2005. Heat shock protein 90 inhibition sensitizes acute myelogenous leukemia cells to cytarabin\hich\af39\dbch\af31505\loch\f39 e. Blood, 106(1), 318-327. PMCID: PMC1895127.
\par \hich\af39\dbch\af31505\loch\f39 Metayer C, Curtis RE, Vose J et al. 2003. Myelodysplastic syndrome and acute myeloid leukemia after autotransplantation for lymphoma: a multicenter case-control study. Blood, 101(5), 2015-2023. PMID: 12393427.
\par \hich\af39\dbch\af31505\loch\f39 Mettler FA, Jr., Huda W, Yoshizumi TT, and Mahesh M. 2008. Effective doses in radiology and diagnostic nuclear medicine: a catalog. Radiology, 248(1), 254-263. PMID: 18566177.
\par \hich\af39\dbch\af31505\loch\f39 Meyer SC, and Levine RL. 2014. Translational implications of somatic genomics in\hich\af39\dbch\af31505\loch\f39  acute myeloid leukaemia. Lancet Oncol, 15(9), e382-394. PMID: 25079101.
\par \hich\af39\dbch\af31505\loch\f39 Mills PK, Beeson WL, Fraser GE, and Phillips RL. 1992. Allergy and cancer: organ site-specific results from the Adventist Health Study. Am J Epidemiol, 136(3), 287-295. PMID: 1415150.
\par \hich\af39\dbch\af31505\loch\f39 Morton LM, Dores GM, Tucker MA et al. 2013. Evolving risk of therapy-related acute myeloid leukemia following cancer chemotherapy among adults in the United States, 1975-2008. Blood, 121(15), 2996-3004. PMCID: PMC3624944.

\par \hich\af39\dbch\af31505\loch\f39 Morton LM, Gibson TM, Clarke CA et al. 2014. Risk of myeloid neoplasms after solid organ transplantation. Leukemia, 28(12), 2317-2323. PMCID: PMC4197126.
\par \hich\af39\dbch\af31505\loch\f39 Muirhead CR, Bingham D, Haylock RG et al. 2003. Follow up of mortality and incidence of cancer 1952-98\hich\af39\dbch\af31505\loch\f39 
 in men from the UK who participated in the UK's atmospheric nuclear weapon tests and experimental programmes. Occup Environ Med, 60(3), 165-172. PMCID: PMC1740497.
\par \hich\af39\dbch\af31505\loch\f39 Muirhead CR, O'Hagan JA, Haylock RG et al. 2009. Mortality and cancer incidence following o\hich\af39\dbch\af31505\loch\f39 
ccupational radiation exposure: third analysis of the National Registry for Radiation Workers. Br J Cancer, 100(1), 206-212. PMCID: PMC2634664.
\par \hich\af39\dbch\af31505\loch\f39 Musselman JR, Blair CK, Cerhan JR et al. 2013. Risk of adult acute and chronic myeloid leukemia with cigarette s\hich\af39\dbch\af31505\loch\f39 moking and cessation. Cancer Epidemiol, 37(4), 410-416. PMCID: PMC3819424.

\par \hich\af39\dbch\af31505\loch\f39 Nardi V, Winkfield KM, Ok CY et al. 2012. Acute myeloid leukemia and myelodysplastic syndromes after radiation therapy are similar to de novo disease and differ from other therapy-r\hich\af39\dbch\af31505\loch\f39 
elated myeloid neoplasms. J Clin Oncol, 30(19), 2340-2347. PMID: 22585703.
\par \hich\af39\dbch\af31505\loch\f39 NCRP (National Council on Radiation Protection and Measurements). 2009. Ionizing radiation exposure of the population of the United States. Bethesda, MD: NCRP.
\par \hich\af39\dbch\af31505\loch\f39 NCRP (National Counci\hich\af39\dbch\af31505\loch\f39 l on Radiation Protection and Measurements). 2011. Second primary cancers and cardiovascular disease after radiation therapy. Bethesda, MD: NCRP.
\par \hich\af39\dbch\af31505\loch\f39 Ng KC, Tan AM, Chong YY, Lau LC, and Lou J. 1999. Congenital acute megakaryoblastic leukemia (M7) with chromos\hich\af39\dbch\af31505\loch\f39 
omal t(1;22)(p13;q13) translocation in a set of identical twins. J Pediatr Hematol Oncol, 21(5), 428-430. PMID: 10524459.
\par \hich\af39\dbch\af31505\loch\f39 Nickels EM, Soodalter J, Churpek JE, and Godley LA. 2013. Recognizing familial myeloid leukemia in adults. Ther Adv Hematol, 4(4), 254\hich\af39\dbch\af31505\loch\f39 -269. PMCID: PMC3734901.
\par \hich\af39\dbch\af31505\loch\f39 Nitiss JL. 2009. Targeting DNA topoisomerase II in cancer chemotherapy. Nat Rev Cancer, 9(5), 338-350. PMCID: PMC2748742.
\par \hich\af39\dbch\af31505\loch\f39 NRC (National Research Council). 2006. Health Risks from Exposure to Low Levels of Ionizing Radiation: BEIR V\hich\af39\dbch\af31505\loch\f39 II Phase 2. Washington, DC: National Academy of Sciences.
\par \hich\af39\dbch\af31505\loch\f39 Olsen JH, Hahnemann JM, Borresen-Dale AL et al. 2001. Cancer in patients with ataxia-telangiectasia and in their relatives in the nordic countries. Journal of the National Cancer Institute, 93(2), 1
\hich\af39\dbch\af31505\loch\f39 21-127. PMID: 11208881.
\par \hich\af39\dbch\af31505\loch\f39 Owen C, Barnett M, and Fitzgibbon J. 2008. Familial myelodysplasia and acute myeloid leukaemia--a review. British Journal of Haematology, 140(2), 123-132. PMID: 18173751.
\par \hich\af39\dbch\af31505\loch\f39 Pan LL, Huang YM, Wang M et al. 2015. Positional cloning and \hich\af39\dbch\af31505\loch\f39 
next-generation sequencing identified a TGM6 mutation in a large Chinese pedigree with acute myeloid leukaemia. Eur J Hum Genet, 23(2), 218-223. PMCID: PMC4297898.
\par \hich\af39\dbch\af31505\loch\f39 Park JH, Qiao B, Panageas KS et al. 2011. Early death rate in acute promyelocytic leukemia r\hich\af39\dbch\af31505\loch\f39 emains high despite all-trans retinoic acid. Blood, 118(5), 1248-1254. PMID: 21653939.
\par \hich\af39\dbch\af31505\loch\f39 Passamonti F, Rumi E, Arcaini L et al. 2008. Prognostic factors for thrombosis, myelofibrosis, and leukemia in essential thrombocythemia: a study of 605 patients. Haemat\hich\af39\dbch\af31505\loch\f39 
ologica, 93(11), 1645-1651. PMID: 18790799.
\par \hich\af39\dbch\af31505\loch\f39 Passamonti F, Rumi E, Pungolino E et al. 2004. Life expectancy and prognostic factors for survival in patients with polycythemia vera and essential thrombocythemia. Am J Med, 117(10), 755-761. PMID: 15541325.
\par \hich\af39\dbch\af31505\loch\f39 Pat\hich\af39\dbch\af31505\loch\f39 el JP, Gonen M, Figueroa ME et al. 2012. Prognostic relevance of integrated genetic profiling in acute myeloid leukemia. N Engl J Med, 366(12), 1079-1089. PMID: 22417203.
\par \hich\af39\dbch\af31505\loch\f39 Pesatori AC, Consonni D, Tironi A et al. 1993. Cancer in a young population in a diox\hich\af39\dbch\af31505\loch\f39 in-contaminated area. Int J Epidemiol, 22(6), 1010-1013. PMID: 8144281.
\par \hich\af39\dbch\af31505\loch\f39 Pogoda JM, Katz J, McKean-Cowdin R et al. 2005. Prescription drug use and risk of acute myeloid leukemia by French-American-British subtype: results from a Los Angeles County case-cont\hich\af39\dbch\af31505\loch\f39 
rol study. Int J Cancer, 114(4), 634-638. PMID: 15609330.
\par \hich\af39\dbch\af31505\loch\f39 Pogoda JM, Nichols PW, Ross RK et al. 2011. Diagnostic radiography and adult acute myeloid leukaemia: an interview and medical chart review study. Br J Cancer, 104(9), 1482-1486. PMCID: PMC3101931.
\par \hich\af39\dbch\af31505\loch\f39 Polednak AP. 2011. US death rates from myeloproliferative neoplasms, and implications for cancer surveillance. J Registry Manag, 38(2), 87-92. PMID: 22096879.
\par \hich\af39\dbch\af31505\loch\f39 Polednak AP. 2013. Trend (1999-2009) in U.S. death rates from myelodysplastic syndromes: utility \hich\af39\dbch\af31505\loch\f39 
of multiple causes of death in surveillance. Cancer Epidemiol, 37(5), 569-574. PMID: 23773300.
\par \hich\af39\dbch\af31505\loch\f39 Polychronakis I, Dounias G, Makropoulos V, Riza E, and Linos A. 2013. Work-related leukemia: a systematic review. J Occup Med Toxicol, 8(1), 14. PMCID: PMC366814\hich\af39\dbch\af31505\loch\f39 8.
\par \hich\af39\dbch\af31505\loch\f39 Poynter JN, Fonstad R, Blair CK et al. 2013. Exogenous hormone use, reproductive history and risk of adult myeloid leukaemia. Br J Cancer, 109(7), 1895-1898. PMCID: PMC3790163.
\par \hich\af39\dbch\af31505\loch\f39 Poynter JN, Richardson M, Blair CK et al. 2016. Obesity over the life course\hich\af39\dbch\af31505\loch\f39 
 and risk of acute myeloid leukemia and myelodysplastic syndromes. Cancer Epidemiol, 40, 134-140. PMCID: PMC4738058.
\par \hich\af39\dbch\af31505\loch\f39 Preston-Martin S, and Pogoda JM. 2003. Estimation of radiographic doses in a case-cont\hich\af39\dbch\af31505\loch\f39 rol study of acute myelogenous leukemia. Health Phys, 84(2), 245-259. PMID: 12553655.
\par \hich\af39\dbch\af31505\loch\f39 Preston-Martin S, Thomas DC, Yu MC, and Henderson BE. 1989. Diagnostic radiography as a risk factor for chronic myeloid and monocytic leukaemia (CML). Br J Cancer, 59(4),\hich\af39\dbch\af31505\loch\f39 
 639-644. PMCID: PMC2247133.
\par \hich\af39\dbch\af31505\loch\f39 
Purdue MP, Hoppin JA, Blair A, Dosemeci M, and Alavanja MC. 2007. Occupational exposure to organochlorine insecticides and cancer incidence in the Agricultural Health Study. Int J Cancer, 120(3), 642-649. PMCID: PMC1971137.
\par \hich\af39\dbch\af31505\loch\f39 Raa\hich\af39\dbch\af31505\loch\f39 
schou-Nielsen O, Ketzel M, Harbo Poulsen A, and Sorensen M. 2016. Traffic-related air pollution and risk for leukaemia of an adult population. Int J Cancer, 138(5), 1111-1117. PMID: 26415047.
\par \hich\af39\dbch\af31505\loch\f39 Rauscher GH, Shore D, and Sandler DP. 2004. Alcohol intake and i\hich\af39\dbch\af31505\loch\f39 ncidence of de novo adult acute leukemia. Leuk Res, 28(12), 1263-1265. PMID: 15475066.
\par \hich\af39\dbch\af31505\loch\f39 Rauscher GH, Shore D, and Sandler DP. 2004. Hair dye use and risk of adult acute leukemia. Am J Epidemiol, 160(1), 19-25. PMID: 15229113.
\par \hich\af39\dbch\af31505\loch\f39 Richardson D, Sugiyama H, Nishi\hich\af39\dbch\af31505\loch\f39  N et al. 2009. Ionizing radiation and leukemia mortality among Japanese Atomic Bomb Survivors, 1950-2000. Radiat Res, 172(3), 368-382. PMID: 19708786.
\par \hich\af39\dbch\af31505\loch\f39 Richardson DB, Terschuren C, Pohlabeln H, Jockel KH, and Hoffmann W. 2008. Temporal patterns of associat\hich\af39\dbch\af31505\loch\f39 
ion between cigarette smoking and leukemia risk. Cancer Causes Control, 19(1), 43-50. PMID: 17906957.
\par \hich\af39\dbch\af31505\loch\f39 Rinsky RA, Hornung RW, Silver SR, and Tseng CY. 2002. Benzene exposure and hematopoietic mortality: A long-term epidemiologic risk assessment. Am J Ind Me\hich\af39\dbch\af31505\loch\f39 d, 42(6), 474-480. PMID: 12439870.

\par \hich\af39\dbch\af31505\loch\f39 Rivina L, Davoren M, and Schiestl RH. 2014. Radiation-induced myeloid leukemia in murine models. Hum Genomics, 8, 13. PMCID: PMC4128013.
\par \hich\af39\dbch\af31505\loch\f39 Rollig C, Bornhauser M, Thiede C et al. 2011. Long-term prognosis of acute myeloid l\hich\af39\dbch\af31505\loch\f39 
eukemia according to the new genetic risk classification of the European LeukemiaNet recommendations: evaluation of the proposed reporting system. J Clin Oncol, 29(20), 2758-2765. PMID: 21632498.
\par \hich\af39\dbch\af31505\loch\f39 Rommens J, and Durie P. 2008. Shwachman-Diamond syndrome. In\hich\af39\dbch\af31505\loch\f39 : Pagon R, Bird T, Dolan C, and Stephens K (Eds.), GeneReviews [Internet]. Seattle, WA: University of Washington, Seattle.
\par \hich\af39\dbch\af31505\loch\f39 Rosenbaum T, and Wimmer K. 2014. Neurofibromatosis type 1 (NF1) and associated tumors. Klin Padiatr, 226(6-7), 309-315. PMID: 2506211\hich\af39\dbch\af31505\loch\f39 3.
\par \hich\af39\dbch\af31505\loch\f39 Ross JA, Blair CK, Cerhan JR et al. 2011. Nonsteroidal anti-inflammatory drug and acetaminophen use and risk of adult myeloid leukemia. Cancer Epidemiol Biomarkers Prev, 20(8), 1741-1750. PMCID: PMC3153558.
\par \hich\af39\dbch\af31505\loch\f39 Ruhl J, Adamo M, and Dickie L. 2015. Hematopoi\hich\af39\dbch\af31505\loch\f39 etic and Lymphoid Neoplasm Coding Manual. Bethesda: National Cancer Institute.
\par \hich\af39\dbch\af31505\loch\f39 Rushton L, Schnatter AR, Tang G, and Glass DC. 2014. Acute myeloid and chronic lymphoid leukaemias and exposure to low-level benzene among petroleum workers. Br J Cancer, 110(3)\hich\af39\dbch\af31505\loch\f39 
, 783-787. PMCID: PMC3915135.
\par \hich\af39\dbch\af31505\loch\f39 Sakata R, Kleinerman RA, Mabuchi K et al. 2012. Cancer mortality following radiotherapy for benign gynecologic disorders. Radiat Res, 178(4), 266-279. PMCID: PMC3471655.
\par \hich\af39\dbch\af31505\loch\f39 Saliba J, Saint-Martin C, Di Stefano A et al. 2015. Germ\hich\af39\dbch\af31505\loch\f39 line duplication of ATG2B and GSKIP predisposes to familial myeloid malignancies. Nat Genet, 47(10), 1131-1140. PMID: 26280900.

\par \hich\af39\dbch\af31505\loch\f39 Sant M, Allemani C, Tereanu C et al. 2010. Incidence of hematologic malignancies in Europe by morphologic subtype: results of th\hich\af39\dbch\af31505\loch\f39 
e HAEMACARE project. Blood, 116(19), 3724-3734. PMID: 20664057.
\par \hich\af39\dbch\af31505\loch\f39 Saso R, Kulkarni S, Mitchell P et al. 2000. Secondary myelodysplastic syndrome/acute myeloid leukaemia following mitoxantrone-based therapy for breast carcinoma. Br J Cancer, 83(1), 91-94. PMC
\hich\af39\dbch\af31505\loch\f39 ID: PMC2374543.
\par \hich\af39\dbch\af31505\loch\f39 Savage SA, Giri N, Baerlocher GM et al. 2008. TINF2, a component of the shelterin telomere protection complex, is mutated in dyskeratosis congenita. Am J Hum Genet, 82(2), 501-509. PMCID: PMC2427222.
\par \hich\af39\dbch\af31505\loch\f39 SCENIHR (Scientific Committee on Emergin\hich\af39\dbch\af31505\loch\f39 
g and Newly Identified Health Risks). 2015. Potential health effects of exposure to electromagnetic fields (EMF): http://ec.europa.eu/health/scientific_committees/emerging/docs/scenihr_o_041.pdf   
\par \hich\af39\dbch\af31505\loch\f39 Schlenk RF, Dohner K, Krauter J et al. 2008. Mutations and\hich\af39\dbch\af31505\loch\f39  treatment outcome in cytogenetically normal acute myeloid leukemia. N Engl J Med, 358(18), 1909-1918. PMID: 18450602.
\par \hich\af39\dbch\af31505\loch\f39 Schnatter AR, Glass DC, Tang G, Irons RD, and Rushton L. 2012. Myelodysplastic syndrome and benzene exposure among petroleum workers: an \hich\af39\dbch\af31505\loch\f39 
international pooled analysis. J Natl Cancer Inst, 104(22), 1724-1737. PMCID: PMC3502195.
\par \hich\af39\dbch\af31505\loch\f39 Schwilk E, Zhang L, Smith MT, Smith AH, and Steinmaus C. 2010. Formaldehyde and leukemia: an updated meta-analysis and evaluation of bias. J Occup Environ Med, 52(9),\hich\af39\dbch\af31505\loch\f39 
 878-886. PMID: 20798648.
\par \hich\af39\dbch\af31505\loch\f39 
SEER. 2015. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence - SEER 9 Regs Research Data, Nov 2014 Sub (1973-2012) <Katrina/Rita Population Adjustment> - Linked To Coun
\hich\af39\dbch\af31505\loch\f39 ty Attributes - Total U.S., 1969-2013 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released April 2015, based on the November 2014 submission.
\par \hich\af39\dbch\af31505\loch\f39 SEER. 2015. Surveillance, Epidemiology, and End Result\hich\af39\dbch\af31505\loch\f39 
s (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence - SEER 13 Regs Research Data, Nov 2014 Sub (1992-2012) <Katrina/Rita Population Adjustment> - Linked To County Attributes - Total U.S., 1969-2013 Counties, National Cancer Institute, DCC
\hich\af39\dbch\af31505\loch\f39 P\hich\af39\dbch\af31505\loch\f39 S, Surveillance Research Program, Surveillance Systems Branch, released April 2015, based on the November 2014 submission.
\par \hich\af39\dbch\af31505\loch\f39 
SEER. 2015. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence - SEER 18 Regs Research Data + Hurricane Katrina Impacted Louisiana Cases, Nov 2014 Sub (2000-2012) <Katrina/Rita Population Adjustm
\hich\af39\dbch\af31505\loch\f39 e\hich\af39\dbch\af31505\loch\f39 
nt> - Linked To County Attributes - Total U.S., 1969-2013 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released April 2015, based on the November 2014 submission.
\par \hich\af39\dbch\af31505\loch\f39 Seminog OO, and Goldacre MJ. 2013.\hich\af39\dbch\af31505\loch\f39 
 Risk of benign tumours of nervous system, and of malignant neoplasms, in people with neurofibromatosis: population-based record-linkage study. Br J Cancer, 108(1), 193-198. PMCID: PMC3553528.
\par \hich\af39\dbch\af31505\loch\f39 Severson RK, Davis S, Thomas DB et al. 1989. Acute myelocytic l\hich\af39\dbch\af31505\loch\f39 eukemia and prior allergies. J Clin Epidemiol, 42(10), 995-1001. PMID: 2809658.
\par \hich\af39\dbch\af31505\loch\f39 Severson RK, Stevens RG, Kaune WT et al. 1988. Acute nonlymphocytic leukemia and residential exposure to power frequency magnetic fields. Am J Epidemiol, 128(1), 10-20. PMID: 3\hich\af39\dbch\af31505\loch\f39 381818.

\par \hich\af39\dbch\af31505\loch\f39 
Shadman M, White E, De Roos AJ, and Walter RB. 2013. Associations between allergies and risk of hematologic malignancies: results from the VITamins and lifestyle cohort study. Am J Hematol, 88(12), 1050-1054. PMCID: PMC4001851.
\par \hich\af39\dbch\af31505\loch\f39 Shiels MS, and Engel\hich\af39\dbch\af31505\loch\f39 
s EA. 2012. Increased risk of histologically defined cancer subtypes in human immunodeficiency virus-infected individuals: clues for possible immunosuppression-related or infectious etiology. Cancer, 118(19), 4869-4876. PMCID: PMC3366173.
\par \hich\af39\dbch\af31505\loch\f39 Shilnikova NS, Pr\hich\af39\dbch\af31505\loch\f39 eston DL, Ron E et al. 2003. Cancer mortality risk among workers at the Mayak nuclear complex. Radiat Res, 159(6), 787-798. PMID: 12751962.
\par \hich\af39\dbch\af31505\loch\f39 Shimizu Y, Pierce DA, Preston DL, and Mabuchi K. 1999. Studies of the mortality of atomic bomb survivors. Report 12,\hich\af39\dbch\af31505\loch\f39 
 part II. Noncancer mortality: 1950-1990. Radiat Res, 152(4), 374-389. PMID: 10477914.
\par \hich\af39\dbch\af31505\loch\f39 Shizuru JA, Negrin RS, and Weissman IL. 2005. Hematopoietic stem and progenitor cells: clinical and preclinical regeneration of the hematolymphoid system. Annu Rev Med, \hich\af39\dbch\af31505\loch\f39 
56, 509-538. PMID: 15660525.
\par \hich\af39\dbch\af31505\loch\f39 Shlush LI, and Minden MD. 2015. Preleukemia: the normal side of cancer. Curr Opin Hematol, 22(2), 77-84. PMID: 25575035.
\par \hich\af39\dbch\af31505\loch\f39 Shore RE, Moseson M, Harley N, and Pasternack BS. 2003. Tumors and other diseases following childhood x-ra\hich\af39\dbch\af31505\loch\f39 
y treatment for ringworm of the scalp (Tinea capitis). Health Phys, 85(4), 404-408. PMID: 13678280.
\par \hich\af39\dbch\af31505\loch\f39 Shu XO, Gao YT, Linet MS et al. 1987. Chloramphenicol use and childhood leukaemia in Shanghai. Lancet, 2(8565), 934-937. PMID: 2889862.
\par \hich\af39\dbch\af31505\loch\f39 Siegel RL, Miller KD\hich\af39\dbch\af31505\loch\f39 , and Jemal A. 2016. Cancer statistics, 2016. CA Cancer J Clin, 66(1), 7-30. PMID: 26742998.
\par \hich\af39\dbch\af31505\loch\f39 Sielken RL, Jr., and Valdez-Flores C. 2015. A comprehensive review of occupational and general population cancer risk: 1,3-Butadiene exposure-response modeling for\hich\af39\dbch\af31505\loch\f39 
 all leukemia, acute myelogenous leukemia, chronic lymphocytic leukemia, chronic myelogenous leukemia, myeloid neoplasm and lymphoid neoplasm. Chem Biol Interact, 241, 50-58. PMID: 26070419.
\par \hich\af39\dbch\af31505\loch\f39 Simon SL, Preston DL, Linet MS et al. 2014. Radiation organ doses\hich\af39\dbch\af31505\loch\f39 
 received in a nationwide cohort of U.S. radiologic technologists: methods and findings. Radiat Res, 182(5), 507-528. PMCID: PMC4406479.
\par \hich\af39\dbch\af31505\loch\f39 Sinner PJ, Cerhan JR, Folsom AR, and Ross JA. 2005. Positive association of farm or rural residence with acute myeloid \hich\af39\dbch\af31505\loch\f39 
leukemia incidence in a cohort of older women. Cancer Epidemiol Biomarkers Prev, 14(10), 2446-2448. PMID: 16214930.
\par \hich\af39\dbch\af31505\loch\f39 Smith A, Howell D, Patmore R, Jack A, and Roman E. 2011. Incidence of haematological malignancy by sub-type: a report from the Haematologica\hich\af39\dbch\af31505\loch\f39 
l Malignancy Research Network. Br J Cancer, 105(11), 1684-1692. PMCID: 3242607.
\par \hich\af39\dbch\af31505\loch\f39 Smith A, Roman E, Howell D et al. 2009. The Haematological Malignancy Research Network (HMRN): a new information strategy for population based epidemiology and health service r\hich\af39\dbch\af31505\loch\f39 
esearch. Br J Haematol, 148(5), 739-753. PMCID: 3066245.
\par \hich\af39\dbch\af31505\loch\f39 Smith AG, Dovey GJ, and Cartwright RA. 2000. Topical chloramphenicol and the risk of acute leukaemia in adults. Pharmacoepidemiol Drug Saf, 9(3), 215-219. PMID: 19025822.
\par \hich\af39\dbch\af31505\loch\f39 Smith ML, Cavenagh JD, Liste\hich\af39\dbch\af31505\loch\f39 r TA, and Fitzgibbon J. 2004. Mutation of CEBPA in familial acute myeloid leukemia. N Engl J Med, 351(23), 2403-2407. PMID: 15575056.
\par \hich\af39\dbch\af31505\loch\f39 Soderberg KC, Hagmar L, Schwartzbaum J, and Feychting M. 2004. Allergic conditions and risk of hematological malignancies \hich\af39\dbch\af31505\loch\f39 
in adults: a cohort study. BMC Public Health, 4, 51. PMCID: PMC534807.
\par \hich\af39\dbch\af31505\loch\f39 Sokal JE, Cox EB, Baccarani M et al. 1984. Prognostic discrimination in "good-risk" chronic granulocytic leukemia. Blood, 63(4), 789-799. PMID: 6584184.
\par \hich\af39\dbch\af31505\loch\f39 Song WJ, Sullivan MG, Legare RD \hich\af39\dbch\af31505\loch\f39 
et al. 1999. Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia. Nat Genet, 23(2), 166-175. PMID: 10508512.
\par \hich\af39\dbch\af31505\loch\f39 Srour SA, Devesa SS, Morton LM et al. 2016. Incidence and patient survival of myelo\hich\af39\dbch\af31505\loch\f39 
proliferative neoplasms and myelodysplastic/myeloproliferative neoplasms in the United States, 2001-2012. Britsh Journal of Haematology, 172(?).
\par \hich\af39\dbch\af31505\loch\f39 Stebbings JH. 1998. Dose-response analyses of osteonecrosis in New Jersey radium workers point to roles for oth\hich\af39\dbch\af31505\loch\f39 er alpha emitters. Health Phys, 74(5), 602-607. PMID: 9570164.
\par \hich\af39\dbch\af31505\loch\f39 Stevens W, Thomas DC, Lyon JL et al. 1990. Leukemia in Utah and radioactive fallout from the Nevada test site. A case-control study. JAMA, 264(5), 585-591. PMID: 2366297.
\par \hich\af39\dbch\af31505\loch\f39 Storm HH, Jorgensen HO\hich\af39\dbch\af31505\loch\f39 , Kejs AM, and Engholm G. 2006. Depleted uranium and cancer in Danish Balkan veterans deployed 1992-2001. Eur J Cancer, 42(14), 2355-2358. PMID: 16857358.
\par \hich\af39\dbch\af31505\loch\f39 Strom SS, Yamamura Y, Kantarijian HM, and Cortes-Franco JE. 2009. Obesity, weight gain, and risk of chronic myeloid leukemia. Cancer Epidemiol Biomarkers Prev, 18(5), 1501-1506. PMCID: PMC2918285.
\par \hich\af39\dbch\af31505\loch\f39 Strullu M, Caye A, Lachenaud J et al. 2014. Juvenile myelom\hich\af39\dbch\af31505\loch\f39 onocytic leukaemia and Noonan syndrome. J Med Genet, 51(10), 689-697. PMID: 25097206.
\par \hich\af39\dbch\af31505\loch\f39 Swerdlow SH, Campo E, Harris NL et al (Eds.). 2008. WHO classification of tumours of haematopoietic and lymphoid tissues (4 ed.). Lyon: International Agency for Research \hich\af39\dbch\af31505\loch\f39 on Cancer.
\par \hich\af39\dbch\af31505\loch\f39 Talbott EO, Xu X, Youk AO et al. 2011. Risk of leukemia as a result of community exposure to gasoline vapors: a follow-up study. Environ Res, 111(4), 597-602. PMID: 21453914.
\par \hich\af39\dbch\af31505\loch\f39 Tapper W, Jones AV, Kralovics R et al. 2015. Genetic variation at MECO\hich\af39\dbch\af31505\loch\f39 M, TERT, JAK2 and HBS1L-MYB predisposes to myeloproliferative neoplasms. Nat Commun, 6, 6691. PMCID: PMC4396373.
\par \hich\af39\dbch\af31505\loch\f39 Tefferi A, and Pardanani A. 2015. Myeloproliferative Neoplasms: A Contemporary Review. JAMA Oncol, 1(1), 97-105. PMID: 26182311.
\par \hich\af39\dbch\af31505\loch\f39 Thariat J, Mar\hich\af39\dbch\af31505\loch\f39 cy PY, Lacout A et al. 2012. Radiotherapy and radiology: joint efforts for modern radiation planning and practice. Diagn Interv Imaging, 93(5), 342-350. PMID: 22483122.
\par \hich\af39\dbch\af31505\loch\f39 Thygesen LC, Nielsen OJ, and Johansen C. 2009. Trends in adult leukemia incidence and s\hich\af39\dbch\af31505\loch\f39 urvival in Denmark, 1943-2003. Cancer Causes Control, 20(9), 1671-1680. PMID: 19672681.
\par \hich\af39\dbch\af31505\loch\f39 Till JE, Beck HL, Aanenson JW et al. 2014. Military participants at U.S. Atmospheric nuclear weapons testing--methodology for estimating dose and uncertainty. Radiat Re\hich\af39\dbch\af31505\loch\f39 
s, 181(5), 471-484. PMCID: PMC4082990.
\par \hich\af39\dbch\af31505\loch\f39 Tomasek L, Darby SC, Swerdlow AJ, Placek V, and Kunz E. 1993. Radon exposure and cancers other than lung cancer among uranium miners in West Bohemia. Lancet, 341(8850), 919-923. PMID: 8096265.
\par \hich\af39\dbch\af31505\loch\f39 Tong H, Hu C, Yin X et a\hich\af39\dbch\af31505\loch\f39 l. 2013. A Meta-Analysis of the Relationship between Cigarette Smoking and Incidence of Myelodysplastic Syndromes. PLoS One, 8(6), e67537. PMCID: PMC3689714.
\par \hich\af39\dbch\af31505\loch\f39 Traversa G, Menniti-Ippolito F, Da Cas R et al. 1998. Drug use and acute leukemia. Pharmacoepidemi\hich\af39\dbch\af31505\loch\f39 ol Drug Saf, 7(2), 113-123. PMID: 15073735.
\par \hich\af39\dbch\af31505\loch\f39 Travis LB, Hauptmann M, Gaul LK et al. 2003. Site-specific cancer incidence and mortality after cerebral angiography with radioactive thorotrast. Radiat Res, 160(6), 691-706. PMID: 14640794.
\par \hich\af39\dbch\af31505\loch\f39 Travis LB, Holowaty E\hich\af39\dbch\af31505\loch\f39 J, Bergfeldt K et al. 1999. Risk of leukemia after platinum-based chemotherapy for ovarian cancer. N Engl J Med, 340(5), 351-357. PMID: 9929525.
\par \hich\af39\dbch\af31505\loch\f39 Tucker JD. 2010. Chromosome translocations and assessing human exposure to adverse environmental agents. Enviro\hich\af39\dbch\af31505\loch\f39 n Mol Mutagen, 51(8-9), 815-824. PMID: 20213842.
\par \hich\af39\dbch\af31505\loch\f39 Tynes T, and Haldorsen T. 2003. Residential and occupational exposure to 50 Hz magnetic fields and hematological cancers in Norway. Cancer Causes Control, 14(8), 715-720. PMID: 14674735.
\par \hich\af39\dbch\af31505\loch\f39 Udayakumar AM, Surek\hich\af39\dbch\af31505\loch\f39 
hatony M, and Wali YA. 2014. Myelodysplasia progressing to acute myeloid leukemia in monozygotic twins with monosomy 7 as sole abnormality. Leuk Lymphoma, 55(11), 2672-2674. PMID: 24598016.
\par \hich\af39\dbch\af31505\loch\f39 Vardiman JW, Harris NL, and Brunning RD. 2002. The World Health Or\hich\af39\dbch\af31505\loch\f39 ganization (WHO) classification of the myeloid neoplasms. Blood, 100(7), 2292-2302. PMID: 12239137.
\par \hich\af39\dbch\af31505\loch\f39 Vardiman JW, Thiele J, Arber DA et al. 2009. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia\hich\af39\dbch\af31505\loch\f39 
: rationale and important changes. Blood, 114(5), 937-951. PMID: 19357394.
\par \hich\af39\dbch\af31505\loch\f39 Varley J, Evans D, and Birch J. 1997. Li-Fraumeni syndrome--a molecular and clinical review. British Journal of Cancer, 76(1), 1-14.
\par \hich\af39\dbch\af31505\loch\f39 Verkasalo PK, Pukkala E, Kaprio J, Heikkila KV, \hich\af39\dbch\af31505\loch\f39 
and Koskenvuo M. 1996. Magnetic fields of high voltage power lines and risk of cancer in Finnish adults: nationwide cohort study. BMJ, 313(7064), 1047-1051. PMCID: PMC2352388.
\par \hich\af39\dbch\af31505\loch\f39 Vijayakrishnan J, and Houlston R. 2010. Candidate gene association studies and r\hich\af39\dbch\af31505\loch\f39 
isk of childhood acute lymphoblastic leukemia: A systematic review and meta-analysis. Haematologica, 95(8), 1405-1414. PMID: 20511665.
\par \hich\af39\dbch\af31505\loch\f39 Visser O, Trama A, Maynadie M et al. 2012. Incidence, survival and prevalence of myeloid malignancies in Europe. Eur J Ca\hich\af39\dbch\af31505\loch\f39 ncer, 48(17), 3257-3266. PMID: 22770878.
\par \hich\af39\dbch\af31505\loch\f39 Vlaanderen J, Lan Q, Kromhout H, Rothman N, and Vermeulen R. 2012. Occupational benzene exposure and the risk of chronic myeloid leukemia: a meta-analysis of cohort studies incorporating study quality dimensions. Am
\hich\af39\dbch\af31505\loch\f39  J Ind Med, 55(9), 779-785. PMID: 22729623.
\par \hich\af39\dbch\af31505\loch\f39 Voso MT, Fenu S, Latagliata R et al. 2013. Revised International Prognostic Scoring System (IPSS) predicts survival and leukemic evolution of myelodysplastic syndromes significantly better than IPSS and WHO Progn
\hich\af39\dbch\af31505\loch\f39 ostic Scoring System: validation by the Gruppo Romano Mielodisplasie Italian Regional Database. J Clin Oncol, 31(21), 2671-2677. PMID: 23796988.
\par \hich\af39\dbch\af31505\loch\f39 Wakeford R. 2009. Radiation in the workplace-a review of studies of the risks of occupational exposure to ionis\hich\af39\dbch\af31505\loch\f39 ing radiation. J Radiol Prot, 29(2A), A61-79. PMID: 19454806.
\par \hich\af39\dbch\af31505\loch\f39 Wang P, Liu H, Jiang T, and Yang J. 2015. Cigarette Smoking and the Risk of Adult Myeloid Disease: A Meta-Analysis. PLoS One, 10(9), e0137300. PMCID: PMC4560392.
\par \hich\af39\dbch\af31505\loch\f39 Wei L, and Sugahara T. 2000. An introductory overview of the epidemiological study on the population at the high background radiation areas in Yangjiang, China. J Radiat Res, 41 Suppl, 1-7. PMID: 11142208.
\par \hich\af39\dbch\af31505\loch\f39 Weiss HA, Darby SC, Fearn T, and Doll R. 1995. Leu\hich\af39\dbch\af31505\loch\f39 kemia mortality after X-ray treatment for ankylosing spondylitis. Radiat Res, 142(1), 1-11. PMID: 7899552.
\par \hich\af39\dbch\af31505\loch\f39 Weiss JR, Baker JA, Baer MR et al. 2006. Opposing effects of aspirin and acetaminophen use on risk of adult acute leukemia. Leuk Res, 30(2), 164-169.\hich\af39\dbch\af31505\loch\f39  PMID: 16099041.
\par \hich\af39\dbch\af31505\loch\f39 Wheatley K, Brookes CL, Howman AJ et al. 2009. Prognostic factor analysis of the survival of elderly patients with AML in the MRC AML11 and LRF AML14 trials. Br J Haematol, 145(5), 598-605. PMID: 19344426.
\par \hich\af39\dbch\af31505\loch\f39 Wick RR, Nekolla EA, Gaubitz M, a\hich\af39\dbch\af31505\loch\f39 
nd Schulte TL. 2008. Increased risk of myeloid leukaemia in patients with ankylosing spondylitis following treatment with radium-224. Rheumatology (Oxford), 47(6), 855-859. PMID: 18390588.
\par \hich\af39\dbch\af31505\loch\f39 Wilkinson P, Thakrar B, Walls P et al. 1999. Lymphohaematopoietic m\hich\af39\dbch\af31505\loch\f39 
alignancy around all industrial complexes that include major oil refineries in Great Britain. Occup Environ Med, 56(9), 577-580. PMCID: PMC1757785.
\par \hich\af39\dbch\af31505\loch\f39 Williams RR, and Horm JW. 1977. Association of cancer sites with tobacco and alcohol consumption and socioec\hich\af39\dbch\af31505\loch\f39 
onomic status of patients: interview study from the Third National Cancer Survey. J Natl Cancer Inst, 58(3), 525-547. PMID: 557114.
\par \hich\af39\dbch\af31505\loch\f39 Wong O, Harris F, Yiying W, and Hua F. 2009. A hospital-based case-control study of acute myeloid leukemia in Shanghai: anal\hich\af39\dbch\af31505\loch\f39 
ysis of personal characteristics, lifestyle and environmental risk factors by subtypes of the WHO classification. Regul Toxicol Pharmacol, 55(3), 340-352. PMID: 19703505.
\par \hich\af39\dbch\af31505\loch\f39 Wright JD, St Clair CM, Deutsch I et al. 2010. Pelvic radiotherapy and the risk of se\hich\af39\dbch\af31505\loch\f39 condary leukemia and multiple myeloma. Cancer, 116(10), 2486-2492. PMID: 20209618.
\par \hich\af39\dbch\af31505\loch\f39 Xavier AC, and Taub JW. 2010. Acute leukemia in children with Down syndrome. Haematologica, 95(7), 1043-1045.
\par \hich\af39\dbch\af31505\loch\f39 Yamamura Y, Oum R, Gbito KY, Garcia-Manero G, and Strom SS. 201\hich\af39\dbch\af31505\loch\f39 
3. Dietary intake of vegetables, fruits, and meats/beans as potential risk factors of acute myeloid leukemia: a Texas case-control study. Nutr Cancer, 65(8), 1132-1140. PMID: 24168094.
\par \hich\af39\dbch\af31505\loch\f39 Yenson PR, Forrest D, Schmiegelow K, and Dalal BI. 2008. Azathioprine-a\hich\af39\dbch\af31505\loch\f39 
ssociated acute myeloid leukemia in a patient with Crohn's disease and thiopurine S-methyltransferase deficiency. Am J Hematol, 83(1), 80-83. PMID: 17696202.
\par \hich\af39\dbch\af31505\loch\f39 Yoshinaga S, Mabuchi K, Sigurdson AJ, Doody MM, and Ron E. 2004. Cancer risks among radiologists a\hich\af39\dbch\af31505\loch\f39 
nd radiologic technologists: review of epidemiologic studies. Radiology, 233(2), 313-321. PMID: 15375227.
\par \hich\af39\dbch\af31505\loch\f39 Zablotska LB, Bazyka D, Lubin JH et al. 2013. Radiation and the risk of chronic lymphocytic and other leukemias among chornobyl cleanup workers. Envir\hich\af39\dbch\af31505\loch\f39 
on Health Perspect, 121(1), 59-65. PMCID: PMC3553431.
\par \hich\af39\dbch\af31505\loch\f39 Zablotska LB, Lane RS, Frost SE, and Thompson PA. 2014. Leukemia, lymphoma and multiple myeloma mortality (1950-1999) and incidence (1969-1999) in the Eldorado uranium workers cohort. Environ Res, 130, 
\hich\af39\dbch\af31505\loch\f39 43-50. PMCID: PMC4002578.
\par \hich\af39\dbch\af31505\loch\f39 Zeichner SB, and Arellano ML. 2015. Secondary Adult Acute Myeloid Leukemia: a Review of Our Evolving Understanding of a Complex Disease Process. Curr Treat Options Oncol, 16(8), 37. PMID: 26143266.
\par \hich\af39\dbch\af31505\loch\f39 Zhang L, Tang X, Rothman N et al\hich\af39\dbch\af31505\loch\f39 
. 2010. Occupational exposure to formaldehyde, hematotoxicity, and leukemia-specific chromosome changes in cultured myeloid progenitor cells. Cancer Epidemiol Biomarkers Prev, 19(1), 80-88. PMCID: PMC2974570.
\par \hich\af39\dbch\af31505\loch\f39 Zhang Y, Kim C, and Zheng T. 2012. Hair dye use\hich\af39\dbch\af31505\loch\f39  and risk of human cancer. Front Biosci (Elite Ed), 4, 516-528. PMID: 22201892.
\par \hich\af39\dbch\af31505\loch\f39 Zheng W, Linet MS, Shu XO et al. 1993. Prior medical conditions and the risk of adult leukemia in Shanghai, People's Republic of China. Cancer Causes Control, 4(4), 361-368. PM\hich\af39\dbch\af31505\loch\f39 ID: 8347786.

\par \hich\af39\dbch\af31505\loch\f39 
Zhou J, Eksioglu EA, Fortenbery NR et al. 2011. Bone marrow mononuclear cells up-regulate toll-like receptor expression and produce inflammatory mediators in response to cigarette smoke extract. PLoS One, 6(6), e21173. PMCID: PMC3126797.}{\rtlch\fcs1 
\af39\afs18 \ltrch\fcs0 \f39\fs18\insrsid12990471 
\par }{\*\themedata 504b030414000600080000002100e9de0fbfff0000001c020000130000005b436f6e74656e745f54797065735d2e786d6cac91cb4ec3301045f748fc83e52d4a
9cb2400825e982c78ec7a27cc0c8992416c9d8b2a755fbf74cd25442a820166c2cd933f79e3be372bd1f07b5c3989ca74aaff2422b24eb1b475da5df374fd9ad
5689811a183c61a50f98f4babebc2837878049899a52a57be670674cb23d8e90721f90a4d2fa3802cb35762680fd800ecd7551dc18eb899138e3c943d7e503b6
b01d583deee5f99824e290b4ba3f364eac4a430883b3c092d4eca8f946c916422ecab927f52ea42b89a1cd59c254f919b0e85e6535d135a8de20f20b8c12c3b0
0c895fcf6720192de6bf3b9e89ecdbd6596cbcdd8eb28e7c365ecc4ec1ff1460f53fe813d3cc7f5b7f020000ffff0300504b030414000600080000002100a5d6
a7e7c0000000360100000b0000005f72656c732f2e72656c73848fcf6ac3300c87ef85bd83d17d51d2c31825762fa590432fa37d00e1287f68221bdb1bebdb4f
c7060abb0884a4eff7a93dfeae8bf9e194e720169aaa06c3e2433fcb68e1763dbf7f82c985a4a725085b787086a37bdbb55fbc50d1a33ccd311ba548b6309512
0f88d94fbc52ae4264d1c910d24a45db3462247fa791715fd71f989e19e0364cd3f51652d73760ae8fa8c9ffb3c330cc9e4fc17faf2ce545046e37944c69e462
a1a82fe353bd90a865aad41ed0b5b8f9d6fd010000ffff0300504b0304140006000800000021006b799616830000008a0000001c0000007468656d652f746865
6d652f7468656d654d616e616765722e786d6c0ccc4d0ac3201040e17da17790d93763bb284562b2cbaebbf600439c1a41c7a0d29fdbd7e5e38337cedf14d59b
4b0d592c9c070d8a65cd2e88b7f07c2ca71ba8da481cc52c6ce1c715e6e97818c9b48d13df49c873517d23d59085adb5dd20d6b52bd521ef2cdd5eb9246a3d8b
4757e8d3f729e245eb2b260a0238fd010000ffff0300504b03041400060008000000210030dd4329a8060000a41b0000160000007468656d652f7468656d652f
7468656d65312e786d6cec594f6fdb3614bf0fd87720746f6327761a07758ad8b19b2d4d1bc46e871e698996d850a240d2497d1bdae38001c3ba618715d86d87
615b8116d8a5fb34d93a6c1dd0afb0475292c5585e9236d88aad3e2412f9e3fbff1e1fa9abd7eec70c1d1221294fda5efd72cd4324f1794093b0eddd1ef62fad
79482a9c0498f184b4bd2991deb58df7dfbb8ad755446282607d22d771db8b944ad79796a40fc3585ee62949606ecc458c15bc8a702910f808e8c66c69b9565b
5d8a314d3c94e018c8de1a8fa94fd05093f43672e23d06af89927ac06762a049136785c10607758d9053d965021d62d6f6804fc08f86e4bef210c352c144dbab
999fb7b4717509af678b985ab0b6b4ae6f7ed9ba6c4170b06c788a705430adf71bad2b5b057d03606a1ed7ebf5babd7a41cf00b0ef83a6569632cd467faddec9
699640f6719e76b7d6ac355c7c89feca9cccad4ea7d36c65b258a206641f1b73f8b5da6a6373d9c11b90c537e7f08dce66b7bbeae00dc8e257e7f0fd2badd586
8b37a088d1e4600ead1ddaef67d40bc898b3ed4af81ac0d76a197c86826828a24bb318f3442d8ab518dfe3a20f000d6458d104a9694ac6d88728eee2782428d6
0cf03ac1a5193be4cbb921cd0b495fd054b5bd0f530c1931a3f7eaf9f7af9e3f45c70f9e1d3ff8e9f8e1c3e3073f5a42ceaa6d9c84e5552fbffdeccfc71fa33f
9e7ef3f2d117d57859c6fffac327bffcfc793510d26726ce8b2f9ffcf6ecc98baf3efdfdbb4715f04d814765f890c644a29be408edf3181433567125272371be
15c308d3f28acd249438c19a4b05fd9e8a1cf4cd296699771c393ac4b5e01d01e5a30a787d72cf1178108989a2159c77a2d801ee72ce3a5c545a6147f32a9979
3849c26ae66252c6ed637c58c5bb8b13c7bfbd490a75330f4b47f16e441c31f7184e140e494214d273fc80900aedee52ead87597fa824b3e56e82e451d4c2b4d
32a423279a668bb6690c7e9956e90cfe766cb37b077538abd27a8b1cba48c80acc2a841f12e698f13a9e281c57911ce298950d7e03aba84ac8c154f8655c4f2a
f074481847bd804859b5e696007d4b4edfc150b12addbecba6b18b148a1e54d1bc81392f23b7f84137c2715a851dd0242a633f900710a218ed715505dfe56e86
e877f0034e16bafb0e258ebb4faf06b769e888340b103d331115bebc4eb813bf83291b63624a0d1475a756c734f9bbc2cd28546ecbe1e20a3794ca175f3fae90
fb6d2dd99bb07b55e5ccf68942bd0877b23c77b908e8db5f9db7f024d9239010f35bd4bbe2fcae387bfff9e2bc289f2fbe24cfaa301468dd8bd846dbb4ddf1c2
ae7b4c191ba8292337a469bc25ec3d411f06f53a73e224c5292c8de0516732307070a1c0660d125c7d44553488700a4d7bddd3444299910e254ab984c3a219ae
a4adf1d0f82b7bd46cea4388ad1c12ab5d1ed8e1153d9c9f350a3246aad01c6873462b9ac05999ad5cc988826eafc3acae853a33b7ba11cd1445875ba1b236b1
399483c90bd560b0b0263435085a21b0f22a9cf9356b38ec6046026d77eba3dc2dc60b17e92219e180643ed27acffba86e9c94c7ca9c225a0f1b0cfae0788ad5
4adc5a9aec1b703b8b93caec1a0bd8e5de7b132fe5113cf312503b998e2c2927274bd051db6b35979b1ef271daf6c6704e86c73805af4bdd476216c26593af84
0dfb5393d964f9cc9bad5c313709ea70f561ed3ea7b053075221d51696910d0d339585004b34272bff7213cc7a510a5454a3b349b1b206c1f0af490176745d4b
c663e2abb2b34b23da76f6352ba57ca2881844c1111ab189d8c7e07e1daaa04f40255c77988aa05fe06e4e5bdb4cb9c5394bbaf28d98c1d971ccd20867e556a7
689ec9166e0a522183792b8907ba55ca6e943bbf2a26e52f48957218ffcf54d1fb09dc3eac04da033e5c0d0b8c74a6b43d2e54c4a10aa511f5fb021a07533b20
5ae07e17a621a8e082dafc17e450ffb739676998b48643a4daa7211214f623150942f6a02c99e83b85583ddbbb2c4996113211551257a656ec1139246ca86be0
aadedb3d1441a89b6a929501833b197fee7b9641a3503739e57c732a59b1f7da1cf8a73b1f9bcca0945b874d4393dbbf10b1680f66bbaa5d6f96e77b6f59113d
316bb31a795600b3d256d0cad2fe354538e7566b2bd69cc6cbcd5c38f0e2bcc63058344429dc2121fd07f63f2a7c66bf76e80d75c8f7a1b622f878a18941d840
545fb28d07d205d20e8ea071b283369834296bdaac75d256cb37eb0bee740bbe278cad253b8bbfcf69eca23973d939b97891c6ce2cecd8da8e2d343578f6648a
c2d0383fc818c798cf64e52f597c740f1cbd05df0c264c49134cf09d4a60e8a107260f20f92d47b374e32f000000ffff0300504b030414000600080000002100
0dd1909fb60000001b010000270000007468656d652f7468656d652f5f72656c732f7468656d654d616e616765722e786d6c2e72656c73848f4d0ac2301484f7
8277086f6fd3ba109126dd88d0add40384e4350d363f2451eced0dae2c082e8761be9969bb979dc9136332de3168aa1a083ae995719ac16db8ec8e4052164e89
d93b64b060828e6f37ed1567914b284d262452282e3198720e274a939cd08a54f980ae38a38f56e422a3a641c8bbd048f7757da0f19b017cc524bd62107bd500
1996509affb3fd381a89672f1f165dfe514173d9850528a2c6cce0239baa4c04ca5bbabac4df000000ffff0300504b01022d0014000600080000002100e9de0f
bfff0000001c0200001300000000000000000000000000000000005b436f6e74656e745f54797065735d2e786d6c504b01022d0014000600080000002100a5d6
a7e7c0000000360100000b00000000000000000000000000300100005f72656c732f2e72656c73504b01022d00140006000800000021006b799616830000008a
0000001c00000000000000000000000000190200007468656d652f7468656d652f7468656d654d616e616765722e786d6c504b01022d00140006000800000021
0030dd4329a8060000a41b00001600000000000000000000000000d60200007468656d652f7468656d652f7468656d65312e786d6c504b01022d001400060008
00000021000dd1909fb60000001b0100002700000000000000000000000000b20900007468656d652f7468656d652f5f72656c732f7468656d654d616e616765722e786d6c2e72656c73504b050600000000050005005d010000ad0a00000000}
{\*\colorschememapping 3c3f786d6c2076657273696f6e3d22312e302220656e636f64696e673d225554462d3822207374616e64616c6f6e653d22796573223f3e0d0a3c613a636c724d
617020786d6c6e733a613d22687474703a2f2f736368656d61732e6f70656e786d6c666f726d6174732e6f72672f64726177696e676d6c2f323030362f6d6169
6e22206267313d226c743122207478313d22646b3122206267323d226c743222207478323d22646b322220616363656e74313d22616363656e74312220616363
656e74323d22616363656e74322220616363656e74333d22616363656e74332220616363656e74343d22616363656e74342220616363656e74353d22616363656e74352220616363656e74363d22616363656e74362220686c696e6b3d22686c696e6b2220666f6c486c696e6b3d22666f6c486c696e6b222f3e}
{\*\latentstyles\lsdstimax267\lsdlockeddef0\lsdsemihiddendef1\lsdunhideuseddef1\lsdqformatdef0\lsdprioritydef99{\lsdlockedexcept \lsdsemihidden0 \lsdunhideused0 \lsdqformat1 \lsdpriority0 \lsdlocked0 Normal;
\lsdsemihidden0 \lsdunhideused0 \lsdqformat1 \lsdpriority9 \lsdlocked0 heading 1;\lsdqformat1 \lsdpriority9 \lsdlocked0 heading 2;\lsdqformat1 \lsdpriority9 \lsdlocked0 heading 3;\lsdqformat1 \lsdpriority9 \lsdlocked0 heading 4;
\lsdqformat1 \lsdpriority9 \lsdlocked0 heading 5;\lsdqformat1 \lsdpriority9 \lsdlocked0 heading 6;\lsdqformat1 \lsdpriority9 \lsdlocked0 heading 7;\lsdqformat1 \lsdpriority9 \lsdlocked0 heading 8;\lsdqformat1 \lsdpriority9 \lsdlocked0 heading 9;
\lsdpriority39 \lsdlocked0 toc 1;\lsdpriority39 \lsdlocked0 toc 2;\lsdpriority39 \lsdlocked0 toc 3;\lsdpriority39 \lsdlocked0 toc 4;\lsdpriority39 \lsdlocked0 toc 5;\lsdpriority39 \lsdlocked0 toc 6;\lsdpriority39 \lsdlocked0 toc 7;
\lsdpriority39 \lsdlocked0 toc 8;\lsdpriority39 \lsdlocked0 toc 9;\lsdqformat1 \lsdpriority35 \lsdlocked0 caption;\lsdsemihidden0 \lsdunhideused0 \lsdqformat1 \lsdpriority10 \lsdlocked0 Title;\lsdpriority1 \lsdlocked0 Default Paragraph Font;
\lsdsemihidden0 \lsdunhideused0 \lsdqformat1 \lsdpriority11 \lsdlocked0 Subtitle;\lsdsemihidden0 \lsdunhideused0 \lsdqformat1 \lsdpriority22 \lsdlocked0 Strong;\lsdsemihidden0 \lsdunhideused0 \lsdqformat1 \lsdpriority20 \lsdlocked0 Emphasis;
\lsdsemihidden0 \lsdunhideused0 \lsdpriority59 \lsdlocked0 Table Grid;\lsdunhideused0 \lsdlocked0 Placeholder Text;\lsdsemihidden0 \lsdunhideused0 \lsdqformat1 \lsdpriority1 \lsdlocked0 No Spacing;
\lsdsemihidden0 \lsdunhideused0 \lsdpriority60 \lsdlocked0 Light Shading;\lsdsemihidden0 \lsdunhideused0 \lsdpriority61 \lsdlocked0 Light List;\lsdsemihidden0 \lsdunhideused0 \lsdpriority62 \lsdlocked0 Light Grid;
\lsdsemihidden0 \lsdunhideused0 \lsdpriority63 \lsdlocked0 Medium Shading 1;\lsdsemihidden0 \lsdunhideused0 \lsdpriority64 \lsdlocked0 Medium Shading 2;\lsdsemihidden0 \lsdunhideused0 \lsdpriority65 \lsdlocked0 Medium List 1;
\lsdsemihidden0 \lsdunhideused0 \lsdpriority66 \lsdlocked0 Medium List 2;\lsdsemihidden0 \lsdunhideused0 \lsdpriority67 \lsdlocked0 Medium Grid 1;\lsdsemihidden0 \lsdunhideused0 \lsdpriority68 \lsdlocked0 Medium Grid 2;
\lsdsemihidden0 \lsdunhideused0 \lsdpriority69 \lsdlocked0 Medium Grid 3;\lsdsemihidden0 \lsdunhideused0 \lsdpriority70 \lsdlocked0 Dark List;\lsdsemihidden0 \lsdunhideused0 \lsdpriority71 \lsdlocked0 Colorful Shading;
\lsdsemihidden0 \lsdunhideused0 \lsdpriority72 \lsdlocked0 Colorful List;\lsdsemihidden0 \lsdunhideused0 \lsdpriority73 \lsdlocked0 Colorful Grid;\lsdsemihidden0 \lsdunhideused0 \lsdpriority60 \lsdlocked0 Light Shading Accent 1;
\lsdsemihidden0 \lsdunhideused0 \lsdpriority61 \lsdlocked0 Light List Accent 1;\lsdsemihidden0 \lsdunhideused0 \lsdpriority62 \lsdlocked0 Light Grid Accent 1;\lsdsemihidden0 \lsdunhideused0 \lsdpriority63 \lsdlocked0 Medium Shading 1 Accent 1;
\lsdsemihidden0 \lsdunhideused0 \lsdpriority64 \lsdlocked0 Medium Shading 2 Accent 1;\lsdsemihidden0 \lsdunhideused0 \lsdpriority65 \lsdlocked0 Medium List 1 Accent 1;\lsdunhideused0 \lsdlocked0 Revision;
\lsdsemihidden0 \lsdunhideused0 \lsdqformat1 \lsdpriority34 \lsdlocked0 List Paragraph;\lsdsemihidden0 \lsdunhideused0 \lsdqformat1 \lsdpriority29 \lsdlocked0 Quote;\lsdsemihidden0 \lsdunhideused0 \lsdqformat1 \lsdpriority30 \lsdlocked0 Intense Quote;
\lsdsemihidden0 \lsdunhideused0 \lsdpriority66 \lsdlocked0 Medium List 2 Accent 1;\lsdsemihidden0 \lsdunhideused0 \lsdpriority67 \lsdlocked0 Medium Grid 1 Accent 1;\lsdsemihidden0 \lsdunhideused0 \lsdpriority68 \lsdlocked0 Medium Grid 2 Accent 1;
\lsdsemihidden0 \lsdunhideused0 \lsdpriority69 \lsdlocked0 Medium Grid 3 Accent 1;\lsdsemihidden0 \lsdunhideused0 \lsdpriority70 \lsdlocked0 Dark List Accent 1;\lsdsemihidden0 \lsdunhideused0 \lsdpriority71 \lsdlocked0 Colorful Shading Accent 1;
\lsdsemihidden0 \lsdunhideused0 \lsdpriority72 \lsdlocked0 Colorful List Accent 1;\lsdsemihidden0 \lsdunhideused0 \lsdpriority73 \lsdlocked0 Colorful Grid Accent 1;\lsdsemihidden0 \lsdunhideused0 \lsdpriority60 \lsdlocked0 Light Shading Accent 2;
\lsdsemihidden0 \lsdunhideused0 \lsdpriority61 \lsdlocked0 Light List Accent 2;\lsdsemihidden0 \lsdunhideused0 \lsdpriority62 \lsdlocked0 Light Grid Accent 2;\lsdsemihidden0 \lsdunhideused0 \lsdpriority63 \lsdlocked0 Medium Shading 1 Accent 2;
\lsdsemihidden0 \lsdunhideused0 \lsdpriority64 \lsdlocked0 Medium Shading 2 Accent 2;\lsdsemihidden0 \lsdunhideused0 \lsdpriority65 \lsdlocked0 Medium List 1 Accent 2;\lsdsemihidden0 \lsdunhideused0 \lsdpriority66 \lsdlocked0 Medium List 2 Accent 2;
\lsdsemihidden0 \lsdunhideused0 \lsdpriority67 \lsdlocked0 Medium Grid 1 Accent 2;\lsdsemihidden0 \lsdunhideused0 \lsdpriority68 \lsdlocked0 Medium Grid 2 Accent 2;\lsdsemihidden0 \lsdunhideused0 \lsdpriority69 \lsdlocked0 Medium Grid 3 Accent 2;
\lsdsemihidden0 \lsdunhideused0 \lsdpriority70 \lsdlocked0 Dark List Accent 2;\lsdsemihidden0 \lsdunhideused0 \lsdpriority71 \lsdlocked0 Colorful Shading Accent 2;\lsdsemihidden0 \lsdunhideused0 \lsdpriority72 \lsdlocked0 Colorful List Accent 2;
\lsdsemihidden0 \lsdunhideused0 \lsdpriority73 \lsdlocked0 Colorful Grid Accent 2;\lsdsemihidden0 \lsdunhideused0 \lsdpriority60 \lsdlocked0 Light Shading Accent 3;\lsdsemihidden0 \lsdunhideused0 \lsdpriority61 \lsdlocked0 Light List Accent 3;
\lsdsemihidden0 \lsdunhideused0 \lsdpriority62 \lsdlocked0 Light Grid Accent 3;\lsdsemihidden0 \lsdunhideused0 \lsdpriority63 \lsdlocked0 Medium Shading 1 Accent 3;\lsdsemihidden0 \lsdunhideused0 \lsdpriority64 \lsdlocked0 Medium Shading 2 Accent 3;
\lsdsemihidden0 \lsdunhideused0 \lsdpriority65 \lsdlocked0 Medium List 1 Accent 3;\lsdsemihidden0 \lsdunhideused0 \lsdpriority66 \lsdlocked0 Medium List 2 Accent 3;\lsdsemihidden0 \lsdunhideused0 \lsdpriority67 \lsdlocked0 Medium Grid 1 Accent 3;
\lsdsemihidden0 \lsdunhideused0 \lsdpriority68 \lsdlocked0 Medium Grid 2 Accent 3;\lsdsemihidden0 \lsdunhideused0 \lsdpriority69 \lsdlocked0 Medium Grid 3 Accent 3;\lsdsemihidden0 \lsdunhideused0 \lsdpriority70 \lsdlocked0 Dark List Accent 3;
\lsdsemihidden0 \lsdunhideused0 \lsdpriority71 \lsdlocked0 Colorful Shading Accent 3;\lsdsemihidden0 \lsdunhideused0 \lsdpriority72 \lsdlocked0 Colorful List Accent 3;\lsdsemihidden0 \lsdunhideused0 \lsdpriority73 \lsdlocked0 Colorful Grid Accent 3;
\lsdsemihidden0 \lsdunhideused0 \lsdpriority60 \lsdlocked0 Light Shading Accent 4;\lsdsemihidden0 \lsdunhideused0 \lsdpriority61 \lsdlocked0 Light List Accent 4;\lsdsemihidden0 \lsdunhideused0 \lsdpriority62 \lsdlocked0 Light Grid Accent 4;
\lsdsemihidden0 \lsdunhideused0 \lsdpriority63 \lsdlocked0 Medium Shading 1 Accent 4;\lsdsemihidden0 \lsdunhideused0 \lsdpriority64 \lsdlocked0 Medium Shading 2 Accent 4;\lsdsemihidden0 \lsdunhideused0 \lsdpriority65 \lsdlocked0 Medium List 1 Accent 4;
\lsdsemihidden0 \lsdunhideused0 \lsdpriority66 \lsdlocked0 Medium List 2 Accent 4;\lsdsemihidden0 \lsdunhideused0 \lsdpriority67 \lsdlocked0 Medium Grid 1 Accent 4;\lsdsemihidden0 \lsdunhideused0 \lsdpriority68 \lsdlocked0 Medium Grid 2 Accent 4;
\lsdsemihidden0 \lsdunhideused0 \lsdpriority69 \lsdlocked0 Medium Grid 3 Accent 4;\lsdsemihidden0 \lsdunhideused0 \lsdpriority70 \lsdlocked0 Dark List Accent 4;\lsdsemihidden0 \lsdunhideused0 \lsdpriority71 \lsdlocked0 Colorful Shading Accent 4;
\lsdsemihidden0 \lsdunhideused0 \lsdpriority72 \lsdlocked0 Colorful List Accent 4;\lsdsemihidden0 \lsdunhideused0 \lsdpriority73 \lsdlocked0 Colorful Grid Accent 4;\lsdsemihidden0 \lsdunhideused0 \lsdpriority60 \lsdlocked0 Light Shading Accent 5;
\lsdsemihidden0 \lsdunhideused0 \lsdpriority61 \lsdlocked0 Light List Accent 5;\lsdsemihidden0 \lsdunhideused0 \lsdpriority62 \lsdlocked0 Light Grid Accent 5;\lsdsemihidden0 \lsdunhideused0 \lsdpriority63 \lsdlocked0 Medium Shading 1 Accent 5;
\lsdsemihidden0 \lsdunhideused0 \lsdpriority64 \lsdlocked0 Medium Shading 2 Accent 5;\lsdsemihidden0 \lsdunhideused0 \lsdpriority65 \lsdlocked0 Medium List 1 Accent 5;\lsdsemihidden0 \lsdunhideused0 \lsdpriority66 \lsdlocked0 Medium List 2 Accent 5;
\lsdsemihidden0 \lsdunhideused0 \lsdpriority67 \lsdlocked0 Medium Grid 1 Accent 5;\lsdsemihidden0 \lsdunhideused0 \lsdpriority68 \lsdlocked0 Medium Grid 2 Accent 5;\lsdsemihidden0 \lsdunhideused0 \lsdpriority69 \lsdlocked0 Medium Grid 3 Accent 5;
\lsdsemihidden0 \lsdunhideused0 \lsdpriority70 \lsdlocked0 Dark List Accent 5;\lsdsemihidden0 \lsdunhideused0 \lsdpriority71 \lsdlocked0 Colorful Shading Accent 5;\lsdsemihidden0 \lsdunhideused0 \lsdpriority72 \lsdlocked0 Colorful List Accent 5;
\lsdsemihidden0 \lsdunhideused0 \lsdpriority73 \lsdlocked0 Colorful Grid Accent 5;\lsdsemihidden0 \lsdunhideused0 \lsdpriority60 \lsdlocked0 Light Shading Accent 6;\lsdsemihidden0 \lsdunhideused0 \lsdpriority61 \lsdlocked0 Light List Accent 6;
\lsdsemihidden0 \lsdunhideused0 \lsdpriority62 \lsdlocked0 Light Grid Accent 6;\lsdsemihidden0 \lsdunhideused0 \lsdpriority63 \lsdlocked0 Medium Shading 1 Accent 6;\lsdsemihidden0 \lsdunhideused0 \lsdpriority64 \lsdlocked0 Medium Shading 2 Accent 6;
\lsdsemihidden0 \lsdunhideused0 \lsdpriority65 \lsdlocked0 Medium List 1 Accent 6;\lsdsemihidden0 \lsdunhideused0 \lsdpriority66 \lsdlocked0 Medium List 2 Accent 6;\lsdsemihidden0 \lsdunhideused0 \lsdpriority67 \lsdlocked0 Medium Grid 1 Accent 6;
\lsdsemihidden0 \lsdunhideused0 \lsdpriority68 \lsdlocked0 Medium Grid 2 Accent 6;\lsdsemihidden0 \lsdunhideused0 \lsdpriority69 \lsdlocked0 Medium Grid 3 Accent 6;\lsdsemihidden0 \lsdunhideused0 \lsdpriority70 \lsdlocked0 Dark List Accent 6;
\lsdsemihidden0 \lsdunhideused0 \lsdpriority71 \lsdlocked0 Colorful Shading Accent 6;\lsdsemihidden0 \lsdunhideused0 \lsdpriority72 \lsdlocked0 Colorful List Accent 6;\lsdsemihidden0 \lsdunhideused0 \lsdpriority73 \lsdlocked0 Colorful Grid Accent 6;
\lsdsemihidden0 \lsdunhideused0 \lsdqformat1 \lsdpriority19 \lsdlocked0 Subtle Emphasis;\lsdsemihidden0 \lsdunhideused0 \lsdqformat1 \lsdpriority21 \lsdlocked0 Intense Emphasis;
\lsdsemihidden0 \lsdunhideused0 \lsdqformat1 \lsdpriority31 \lsdlocked0 Subtle Reference;\lsdsemihidden0 \lsdunhideused0 \lsdqformat1 \lsdpriority32 \lsdlocked0 Intense Reference;
\lsdsemihidden0 \lsdunhideused0 \lsdqformat1 \lsdpriority33 \lsdlocked0 Book Title;\lsdpriority37 \lsdlocked0 Bibliography;\lsdqformat1 \lsdpriority39 \lsdlocked0 TOC Heading;}}{\*\datastore 010500000200000018000000
4d73786d6c322e534158584d4c5265616465722e362e3000000000000000000000060000
d0cf11e0a1b11ae1000000000000000000000000000000003e000300feff090006000000000000000000000001000000010000000000000000100000feffffff00000000feffffff0000000000000000ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff
ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff
ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff
ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff
fffffffffffffffffdfffffffeffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff
ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff
ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff
ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff
ffffffffffffffffffffffffffffffff52006f006f007400200045006e00740072007900000000000000000000000000000000000000000000000000000000000000000000000000000000000000000016000500ffffffffffffffffffffffff0c6ad98892f1d411a65f0040963251e5000000000000000000000000f04c
707c7ba5d101feffffff00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000ffffffffffffffffffffffff00000000000000000000000000000000000000000000000000000000
00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000ffffffffffffffffffffffff0000000000000000000000000000000000000000000000000000
000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000ffffffffffffffffffffffff000000000000000000000000000000000000000000000000
0000000000000000000000000000000000000000000000000105000000000000}}